US8840601B2 - Intravascular tissue disruption - Google Patents

Intravascular tissue disruption Download PDF

Info

Publication number
US8840601B2
US8840601B2 US13/071,436 US201113071436A US8840601B2 US 8840601 B2 US8840601 B2 US 8840601B2 US 201113071436 A US201113071436 A US 201113071436A US 8840601 B2 US8840601 B2 US 8840601B2
Authority
US
United States
Prior art keywords
fluid
delivery
tissue
control
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13/071,436
Other languages
English (en)
Other versions
US20110257622A1 (en
Inventor
Amr Salahieh
Alan Schaer
Jeff Krolik
John Spiridigliozzi
Suresh Pai
Tom Saul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shifamed Holdings LLC
Original Assignee
Shifamed Holdings LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13/071,436 priority Critical patent/US8840601B2/en
Application filed by Shifamed Holdings LLC filed Critical Shifamed Holdings LLC
Publication of US20110257622A1 publication Critical patent/US20110257622A1/en
Assigned to SHIFAMED, LLC reassignment SHIFAMED, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PAI, SURESH, SCHAER, ALAN, SPIRIDIGLIOZZI, JOHN, KROLIK, JEFF, SALAHIEH, AMR, SAUL, TOM
Priority to US13/351,962 priority patent/US20120116438A1/en
Assigned to SHIFAMED HOLDINGS, LLC reassignment SHIFAMED HOLDINGS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SHIFAMED, LLC
Priority to US13/748,374 priority patent/US20130138082A1/en
Publication of US8840601B2 publication Critical patent/US8840601B2/en
Application granted granted Critical
Priority to US15/092,442 priority patent/US20170080184A1/en
Priority to US15/167,509 priority patent/US20170027601A1/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/0071—Multiple separate lumens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M25/0054—Catheters; Hollow probes characterised by structural features with regions for increasing flexibility
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075—Valve means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082—Catheter tip comprising a tool
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1002—Balloon catheters characterised by balloon shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M2025/0079—Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082—Catheter tip comprising a tool
    • A61M2025/0096—Catheter tip comprising a tool being laterally outward extensions or tools, e.g. hooks or fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A61M25/0662—Guide tubes
    • A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1097—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0484—Alcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/049—Toxic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008—Strength or flexibility characteristics of the catheter tip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0097—Catheters; Hollow probes characterised by the hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible

Definitions

  • Devices that can deliver a fluid from a distal end port of a catheter have been described.
  • Devices have been described that have a valve at a distal port that allows fluid to flow through the valve in an open configuration and prevents fluid from flowing through the valve in a closed configuration.
  • Devices have also been described that can create microfluidic pulsed jets at the distal end of a catheter.
  • intravascular devices that include elements that pierce lumen walls can be deployed within a lumen and deliver medication into a lumen wall. Some devices have a plurality of delivery ports through which fluids are delivered simultaneously.
  • One aspect of the disclosure is a method of controlling the delivery of fluid from a medical delivery device, comprising: a medical device comprising a distal delivery region comprising a plurality of fluid controls; and selectively regulating the flow of a fluid through the plurality of fluid controls.
  • selectively regulating comprises allowing the fluid to be delivered from a first fluid control while minimizing the fluid that is delivered from a second fluid control.
  • selectively regulating comprises increasing the flow of fluid from a first fluid control without increasing the flow of fluid through a second fluid control.
  • selectively regulating comprises increasing the fluid flow from a first fluid control a first amount and increasing the flow of fluid from a second fluid control a second amount, wherein the first amount is different than the second amount.
  • selectively regulating comprising moving a first fluid control from a closed configuration to an open configuration without moving a second fluid control from a closed configuration to an open configuration.
  • Moving the first control to the open configuration can comprise moving a first valve element with a first aperture therein relative to a second valve element with a second aperture therein until the apertures are in alignment.
  • Moving the first fluid control to the open configuration can cause the fluid to flow from the first control at a high velocity, while the fluid flows out of the second fluid control at a low velocity.
  • selectively regulating comprises flowing the fluid out of a first fluid control at a high velocity and flowing the fluid out of a second fluid control at a low velocity.
  • One aspect of the disclosure is a method of regulating the volume of a fluid delivered from a medical device, comprising: a medical device comprising a distal delivery region comprising a fluid control in communication with a fluid source, wherein the fluid control comprises a first control element with a first aperture therein and a second control element with a second aperture therein; positioning the distal delivery region near a target location within a patient; and regulating the volume of fluid released from the fluid control by moving the apertures into alignment to increase the flow of the fluid through the fluid control.
  • the regulating step occurs independently of transience generated at a fluid pressure source.
  • the fluid source is disposed external to the patient, further comprising maintaining a substantially constant pressure at the fluid source.
  • the method can further comprise varying the fluid velocity at the fluid control to regulate the volume of fluid released.
  • regulating the volume of fluid released further comprises moving the apertures out of alignment to decrease the flow of fluid out of the fluid control.
  • the first control element comprises a first tubular member and the second control element comprises a second tubular member disposed within the first tubular member, and wherein moving the apertures into alignment comprises moving the first tubular member relative to the second tubular member to thereby move the first aperture relative to the second aperture.
  • Moving the first tubular member relative to the second tubular member can comprise at least one of axial movement and rotational movement.
  • One aspect of the disclosure is a method of periluminal tissue damage, comprising positioning a delivery device within a lumen without piercing the lumen wall; delivering a fluid agent from the delivery device through the lumen wall; and damaging tissue peripheral to the lumen wall with the fluid agent.
  • the lumen wall comprises an intimal layer, and wherein the damaging step comprises damaging nerve cells peripheral to the intimal layer of the lumen wall.
  • Damaging can comprise damaging nerves cells while minimally damaging tissue in the intimal layer of the vessel wall.
  • the lumen wall can comprise a medial layer, and wherein damaging comprises damaging tissue within the medial layer.
  • Damaging tissue can comprise damaging cells in at least one of a medial layer of the lumen and nerve cells disposed within the adventitial layer.
  • a damage cross section can increases as the radial distance from the intimal layer increases.
  • the delivery device comprises a first fluid control and a second fluid control, wherein delivering comprises delivering the fluid agent from the first fluid control to create a first damage region, and delivering the fluid agent from the second fluid control creates a second damage region, wherein portions of the first and second regions overlap.
  • damaging comprises damaging tissue with the direct mechanical interaction of the fluid.
  • damaging is caused by chemical interactions with the fluid, such as a hypotonic, a hypertonic fluid, a fluid that self-heats on interaction with tissue, a fluid that has a pH significantly different from the pH of the tissue, a fluid that comprises material toxic to the tissue, a fluid that comprises material toxic to a particular tissue, a fluid that comprises material which becomes toxic on interaction with the tissue, or a fluid that comprises material which is capable of absorbing energy delivered from a source external to the body.
  • a hypotonic such as a hypotonic, a hypertonic fluid, a fluid that self-heats on interaction with tissue, a fluid that has a pH significantly different from the pH of the tissue, a fluid that comprises material toxic to the tissue, a fluid that comprises material toxic to a particular tissue, a fluid that comprises material which becomes toxic on interaction with the tissue, or a fluid that comprises material which is capable of absorbing energy delivered from a source external to the body.
  • delivering a fluid agent from the delivery device through the lumen wall comprises delivering the fluid agent towards neural tissue peripheral to an intimal layer of the lumen.
  • damaging comprises damaging renal nerve tissue peripheral to a lumen of a renal artery.
  • damaging renal nerve tissue reduces hypertension.
  • One aspect of the disclosure is an apparatus for releasing fluid within a patient's body, comprising: an elongate member comprising a distal region comprising a plurality of fluid controls, a lumen extending through the distal region and in fluid communication with the plurality of fluid controls, wherein the lumen is adapted to be in fluid communication with a fluid source, wherein each of the plurality of fluid controls is adapted to be selectively addressable to regulate the volume of a fluid that is released from the lumen and out the plurality of fluid controls.
  • the fluid control has a closed configuration and an open configuration, wherein in the closed configuration a substantially smaller volume of fluid, such as no fluid, is allowed to be released out of the fluid control than in the open configuration.
  • the fluid control can be adapted to release the fluid at high velocity.
  • the distal region comprises a plurality of fluid controls in fluid communication with the lumen, each fluid control has open and closed configurations, and wherein each fluid control is adapted to regulate the volume of fluid that is released from the fluid control when the fluid is delivered at high velocity.
  • the plurality of fluid controls can be adapted to be individually opened.
  • the fluid control is adapted to be in fluid communication with a fluid source maintained at a substantially constant pressure. The fluid control can control the volume of fluid that is released from the fluid control while the fluid source is maintained at the substantially constant pressure.
  • One aspect of the disclosure is an apparatus for controllably releasing fluid within a patient's body, comprising: a first tubular element with a first aperture therein; a second tubular element with a second aperture therein, wherein the second tubular element is disposed within the first tubular element and movable relative to the first tubular element, wherein the second tubular element has a lumen therethrough adapted to be in fluid communication with a fluid source, and wherein the apertures have an aligned configuration that allows a fluid to pass from the lumen through the first and second apertures.
  • the apertures have an aligned configuration that allows a fluid to pass through the apertures at a high velocity.
  • the second aperture has a smaller maximum dimension than a maximum dimension of the first aperture.
  • the apparatus further comprises a fluid source maintained at substantially a constant pressure.
  • the apertures can be adapted to release a fluid therethrough at high velocity.
  • the apertures can have an aligned configuration that allows fluid to pass therethrough when the fluid source is maintained at a substantially constant first pressure during a first delivery cycle and when the fluid source is maintained at a substantially constant second pressure during a second delivery cycle, wherein the first and second pressure are different.
  • the first tubular element has a deformed treatment configuration wherein at least a portion of the first tubular element is adapted to engage a lumen wall in which it is positioned.
  • the deformed treatment configuration can be substantially spiral-shaped.
  • the apparatus can further comprise an expandable element that is adapted to deform the first tubular element into contact with the lumen wall.
  • the expandable element can comprise a balloon.
  • the expandable element can be moveable relative to the first tubular element to cause the first tubular element to be deformed into the treatment configuration.
  • the apparatus further comprises a piercing element in fluid communication with the first aperture and extending from the first aperture, wherein the piercing element is adapted to pierce tissue and allow for the fluid to flow from the aperture and out of the piercing element.
  • the apertures have a non-aligned configuration that is adapted to allow fluid to flow therethrough at a low velocity.
  • One aspect of the disclosure is an apparatus for controllably releasing fluid within a patient's body, comprising: an elongate member comprising a distal end, a proximal end, and a therapy portion in between the ends; the therapy portion comprises a plurality of expandable elongate elements, each with a delivery configuration and a treatment configuration, wherein each of the plurality of expandable elongate elements comprises a fluid control, and in the delivery configuration the control faces a first direction and in the treatment configuration the control faces a second direction different than first direction.
  • the second direction is generally orthogonal to a longitudinal axis of the elongate member.
  • the first direction is substantially parallel to a longitudinal axis of the elongate member.
  • the expandable elongate elements are tubular elements, and wherein the fluid controls are provided by removing sections from the tubular elements. In some embodiments the fluid controls are proximal to distal ends of the elongate elements. In some embodiments the expandable elongate elements are adapted to preferentially bend in the region of the fluid ports in the treatment configurations. In some embodiments the expandable elongate elements are self-expanding. In some embodiments the expandable elongate elements are actuatable.
  • FIG. 1 illustrates an exemplary delivery system adapted to remodel tissue.
  • FIG. 2 illustrates an exemplary delivery system including a fluid system.
  • FIGS. 3-6 illustrate an exemplary embodiment of a delivery system incorporating a fluid system and a plurality of expandable tubular elements.
  • FIGS. 7-10 illustrate an exemplary method of remodeling renal nerves surrounding a renal artery.
  • FIG. 11 illustrates an exemplary reconfigurable distal delivery region that is an extension of an elongate delivery member.
  • FIG. 12 illustrates a distal delivery region including an elongate tubular element that has a spiral procedural configuration.
  • FIG. 13 illustrates a distal delivery region including first and second tubular elements that have spiral procedural configurations.
  • FIG. 14 illustrates an exemplary portion of a distal delivery region, wherein a spiral element comprises two spring elements on either side of a valve.
  • FIGS. 15 and 16 illustrate perspective and end views, respectively, of an exemplary embodiment of the distal delivery region that includes a tubular element, and includes a plurality of penetrating remodeling elements.
  • FIGS. 17 and 18 illustrate exemplary embodiments of distal delivery region including a plurality of expandable tubular elements.
  • FIGS. 19 and 20 illustrate exemplary distal delivery regions incorporating expandable balloons.
  • FIGS. 21-24 illustrate distal delivery regions that include incorporates one or more apertures on outer and inner tubular members.
  • FIGS. 25 and 26 illustrate a spiraled distal delivery region expanded in a renal artery.
  • FIGS. 27-32 illustrate exemplary needle valves that can be activated from a proximal end of the delivery system.
  • FIGS. 33-35 illustrate an exemplary embodiment of a metering valve configuration.
  • FIGS. 36 and 37 illustrate a distal delivery region including penetrating remodeling agents deployed within a section of a renal artery.
  • FIG. 38 illustrates an exemplary distal delivery region incorporating a remodeling element that is a needle with a helical configuration.
  • FIG. 39 illustrate a representation of the fluidic performance of the exemplary valve shown in FIG. 42 .
  • FIG. 40 is a figurative representation of the delivery system in terms of its resistive fluidic characteristics.
  • FIG. 41 illustrates a representation of the expected outflow rate as a function d given the resistance characteristics represented in FIG. 40 and a constant pressure supply.
  • FIG. 42 provides a figurative representation of a delivery system incorporating a distal fluid control configured as a shuttle valve.
  • FIG. 43 illustrates the system of FIG. 39 , wherein the shuttle valve is replaced by a needle valve.
  • FIG. 44 illustrates an exemplary distal delivery region wherein a fluid or gas may be used to eject a component capable of external excitation or alternatively a component which upon ejection springs into a shape different than its delivery shape and in so doing damages tissue in its vicinity, thereby causing tissue remodeling.
  • FIG. 45 illustrates a distal delivery region comprising slicing hooks or simple blades which cut tissue on being advanced.
  • FIG. 46 illustrates an exemplary distal delivery region comprising an atherectomy blade that can be spun to facilitate the requisite tissue remodeling.
  • FIG. 47 illustrates an exemplary distal delivery region similar to that in FIG. 36 .
  • the disclosure herein relates generally to disrupting tissue and devices and systems for disrupting tissue. More specifically, the disclosure describes ways to deliver moieties to a target tissue, where the target tissue in general is not at the point of introduction, in such a way that minimal damage is produced in the tissue at the point of introduction. In some embodiments this is accomplished by jetting fluid at high velocity into the target tissue.
  • the disclosure further describes novel agents deliverable in such systems for use in remodeling tissues. Some of these agents comprise a liquid while others do not. Additionally, although not specifically described in detail much of the disclosure may additionally be used in the delivery of therapeutic drugs.
  • Procedures that allow for the disruption or remodeling of tissues peripheral to body lumens, particularly while minimizing disruption to the inner surface of the body lumen and often the tissues comprising the wall of the body lumen are advantageous in a number of medical procedures.
  • Such procedures include but are not limited to: disruption of nerves in the medial and adventitial tissue surrounding body lumens such as arteries and veins, including the renal arteries and pulmonary arteries and veins, disruption of cancerous tissues surrounding body lumens such as the esophagus for the treatment of various cancers, and urethra for treatment of various cancers such as prostate cancer.
  • Such remodeling treatments may additionally be used to shrink tissues such as sphincters of the bowel, urethra, stomach, or intestines, amongst others.
  • the devices described herein are particularly useful for delivering agents to tissues peripheral to body lumens from within the body lumen, they also will have application in the delivery of agents via pathways and/or in locations independent of body lumens. Such uses include treatment of tumor such as those of the liver or lung.
  • the embodiments described herein associated with the delivery of moieties comprising fluids provide one or more of the following advantages over that which has been described: improved ways for controlling the consistency in dose and or velocity for multi jet systems across the jets; ways for controlling the dose; use of a constant pressure source while achieving metered bolus delivery while maintaining high initial fluid velocity and control of fluid velocity; and minimizing leakage of delivered material while not in delivery cycle. Additionally, in some embodiments the delivery of the fluid jets is controlled in a distal region of the delivery system, thereby minimizing negative effects of system capacitance and long fluid channels on rate at which peak fluid velocity is attained at an exit aperture and delivered dosage. Additionally, damage that is caused by moving a fluid jet while it is constantly activated and slicing large areas of tissue may be minimized by minimizing the duration of on cycles.
  • mechanical disruption of the tissue is effected by high velocity fluid jets situated at or near the target site.
  • the jets may be located at the inner surface of a body lumen and directed thru the body lumen towards the target tissue.
  • the jets, as they enter the body lumen, are highly focused and therefore interact with a small area of the adjoining lumen wall and volume of adjoining tissue.
  • the fluid interacts with the tissue and is spread over a larger volume of tissue, disrupting an increasingly larger area of tissue.
  • the direct interaction of the fluid may be to cut, separate, or swell.
  • the jet may be moved to create a slice in adjoining tissue.
  • the jets may additionally be designed such that the shape of the injected fluid volume would be caused to spread in one or two directions normal to the forward direction as it enters the tissue.
  • the source of the high velocity jets may be passed through the inner surface of the lumen wall and into the wall of the body lumen, or the source of the high velocity jets may be passed completely through the body lumen into the tissue surrounding the body wall.
  • the apparatus may also be configured such that combinations of these approaches may be performed.
  • the fluid delivered via the high velocity injection system is an ablative media such as one of those described below.
  • An ablative material may be delivered to the target tissue without passing any portion of the delivery structure through the wall of the body lumen. Since needles or other structures capable of fraying or tearing the body lumen are not passing through the body lumen, no motions associated with the delivery of the delivery structure or those associated with movement of the patient can cause damage to the body lumen. This may be especially important where the body lumen is frail or where a tear in the body lumen could cause uncontrollable bleeding. Additionally, the cross section of a jet will be smaller than a delivery needle of comparable lumen size.
  • Some moieties or agents that can necrose tissue, capable of delivery in the fashion described, are hypertonic or hypotonic solutions which induce drying or bursting of cells.
  • hypertonic simple salt solutions and alcohols may be used to these ends.
  • ETOH and mixtures of ETOH and H2O2 are particularly useful as such ablative fluids.
  • the H2O2 in this mixture brings about additional damage as a result of oxidative stress.
  • Another set of agents useful for necrosing tissues are those which generate heat and can be delivered in the fashion so far described. These materials, upon interaction with each other or the environment of the target tissue, generate heat as a result of an ensuing chemical reaction or solubilization. Examples of materials which when contacted with water in the target tissue begin a reaction which is exothermic include; iron particles, exothermic salts, An exemplary, but incomplete, lists of salts which can be used to this purpose are CaCl2, CaSO4, MgSO4, K2CO3, Na2SO4. These salts when delivered as a suspension in a non-aqueous carrier, such as a light oil or alcohol amongst others, generate heat upon rehydration.
  • a non-aqueous carrier such as a light oil or alcohol amongst others
  • the salts can be finely divided such that surface to volume ratio is increased and therefore the rate of rehydration and heat generation is enhanced.
  • Finely divided salt particles can range in size from about 0.1 to about 100 microns. Especially useful for this purpose would be the suspensions of nanoparticle sized particles of the salts in which the surface to volume ratio is even further enhanced. These nanoparticles having a size range of 10 nm to 100 nm.
  • Nanoparticles of NaCl, delivered in a light oil or reagent grade alcohol, upon delivery to a target tissue will upon solubilization create both an endothermic reaction and a hypertonic local environment.
  • the oxidation of iron particles provides another system which will behave in a fashion similar to that just described for the exothermic salts. Any such system which relies on such reactions and incorporates a particle as part of the delivered material will behave in much the same fashion as the salts and iron particles described above and will also benefit from an increase in surface to volume ratio such as that associated with decreasing the size from micron to nano dimensions.
  • acids and bases such as: HCl and NaOH, or weak acids and metals such as HCl and Mg, catalyzed polymerization reactions such as that for methyl methacrylate resins, many others can be chosen form, which are familiar to those skilled in the art.
  • An acid or base may also be delivered independently of the other.
  • acetic acid is such an example which has a demonstrated usefulness in ablating tumors.
  • nerve toxins such as the botulinun neurotoxins or capsacin.
  • Many other irreversibly acting nerve toxins known to those familiar with the art, may be delivered in this fashion.
  • blood or blood products may be used as an agent.
  • the blood may be separated and only plasma used, or alternatively the platelets and cellular material may be used.
  • preparations containing cells the preparation may be homogenized to break down the cell structures.
  • the preparation may also be thinned with sodium citrate and or heparin or other anti clotting agents may be added.
  • enzymes including neurolytic and necrotizing may be used.
  • Detergents may also be used independently or in combination with any of the fluids described herein.
  • the agent may be deliverable in a low viscosity form and then on interaction with the environment on the target tissue increases in viscosity possibly becoming a gel.
  • An acid solution comprising collagen on introduction to the roughly normal pH of a target tissue, will polymerize forming a resorbable gel like material which may additionally comprise nanoparticles or other materials described herein.
  • disruption or remodeling is achieved by an externally induced interaction between a material delivered to the target tissue and the target tissue.
  • a material delivered to the target tissue Such materials are configured to be delivered to the target site by percutaneous or minimally invasive procedures.
  • the material Upon completion of material delivery, the material is induced to facilitate the remodeling by an energy field which is created at a site external to the body and directed to the target site by non-invasive means.
  • the induced interactions may be creation or release of toxins or necrosing agents, the generation of heat, mechanical disruption or any other means which eventuates the necroses or loss in functionality of cells in the target tissue.
  • These materials may additionally contain agents to enhance their contrast when viewed by radiographic, acoustic, or MRI means. It should be noted that these materials may also be energized from energy sources delivered minimally invasively or percutaneous to locations near the target tissue.
  • One set of materials which may be used for the generation of heat are induced to heat by the application of acoustic energy.
  • examples of such materials include ethyl vinyl acetate, silicone, urethanes and other materials known in the art.
  • Yet another set of materials that can be induced to generate heat are those capable of absorbing electromagnetic energy, in particular changing magnetic fields (inductive heating).
  • examples of such materials include ferrites and other iron bearing materials and materials containing Nickel.
  • heating occurs when an alternating, uniformly high flux density magnetic field induces an alternating current in a lossy conductor.
  • a gapped toroid can generate such a magnetic field.
  • a solenoid's magnetic field can produce the required magnetic field for inductive heating of discrete particles.
  • the external magnetic field could also be used to couple energy into a catheter in place of electrical conductors.
  • the external magnetic field could also be used to actuate or position features of the catheter in place of mechanisms (e.g., pull wires etc.)
  • a magnetic field would be the physical manipulation of a magnetic dipole (or multitude thereof).
  • One use of such a manipulation would be to move a magnetic particle to a desired location in order to deliver a payload.
  • Another use of such a manipulation would be to move a magnetic particle in such a fashion to be disruptive to the surrounding tissue.
  • a means for inducing said magnetic manipulation could be through the use of a 3 dimensional (3D) array of solenoids whose magnetic fields intersect and form a magnetic field vector that manipulates a magnetic particle(s).
  • the necrosing agent is designed to be released or to convert as a function of energy absorption.
  • the fluid delivery means described herein may be used for the delivery of therapeutic agents in addition to ablative agents.
  • One such therapeutic agent is Taxol, which may be used to minimize post treatment stenosis.
  • Hypertensive drugs may also be delivered in this fashion.
  • any of these materials can be configured for delivery by the mechanisms described above or by more conventional means commonly practiced today, such as the use of simple injection from a needle or system of needles delivered to the body lumen in the vicinity of the target tissue.
  • the final spacial geometry of the delivered material may be important.
  • Such a situation exists for example with regard to the denervation or necrosing of adventitial and medial tissue surrounding the renal artery for the treatment of hypertension.
  • an agent can be delivered to renal nerve tissue to disrupt the neural tissue to treat hypertension.
  • the treatment of hypertension can be accomplished by modulating of neural signal transmission along the renal nerve. Modulation includes activation of neural activity, suppression of neural activity, denervation of tissue, ablation of tissue, etc.
  • the relationship between renal nerve signal transmission and hypertension may be found in, for example, U.S. Pat. No. 6,978,174, U.S. Pat. No. 7,162,303, U.S. Pat. No. 7,617,005, U.S. Pat. No. 7,620,451, U.S. Pat. No. 7,653,438, U.S. Pat. No. 7,756,583, U.S. Pat. No. 7,853,333, and U.S. Pub.
  • the above materials may be delivered as solutions with a wide range of viscosities or be viscous gels.
  • the materials either ablative or otherwise so far described may contain contrast agents and or anesthetics.
  • materials may be designed such that on interacting with the target site the viscosity increases or the material gels, or mixed on delivery such that they the viscosity increases or the material gels at the target site.
  • the materials can be formed as a solid designed to be projected into the target tissue thru the body lumen wall and into the target tissue. Such a mechanism could be driven by high velocity fluids, gases, or by mechanical means such as springs.
  • Agents which may be added to enhance contrast for imaging procedures will be dependent on the particular imaging procedure.
  • materials which enhance MRI imaging are Gadolinium, magnetic materials especially those containing nickel, and or ferrites.
  • examples of those for use with acoustical procedures are silicones, metal or metal oxide particles, amongst others known in the art.
  • Examples of such materials useful for radiological procedures are barium sulfate, tantalum powder, or the like. These examples are not exhaustive and many alternatives, familiar to those skilled in the art may be chosen.
  • FIG. 1 illustrates an exemplary delivery system adapted to disrupt tissue peripheral to a body lumen.
  • Delivery system 10 includes handle 11 and elongate delivery member 13 . Associated with a distal portion of elongate member 13 is distal delivery region 14 . Distal delivery region 14 includes one or more fluid controls 16 .
  • Handle 11 includes at least one delivery member actuation element 12 (two shown), and at least one fluid control actuation element 15 (two shown).
  • Delivery member actuation element 12 can be adapted to steer delivery member 13 , including distal delivery region 14 , to a target location within the body. Delivery member actuation element 12 can also be adapted to reconfigure distal delivery region 14 between a delivery configuration and one or more procedural configurations.
  • Fluid control actuation element 15 is adapted to actuate fluid controls 16 to effect peripheral tissue remodeling.
  • FIG. 2 illustrates an exemplary delivery system with a fluid system.
  • system 20 is represented as an assembly of components separate from handle 11 , fluid system 20 may be incorporated within handle 11 .
  • Fluid system 20 includes fluid reservoir 21 and optional additional reservoirs 22 .
  • Reservoir(s) interface with pressure source 23 which provides the motive force for delivering an agent to fluid controls 16 (see FIG. 1 ). Tissue disruption is mediated by the delivery of an agent from the fluid reservoirs to fluid controls 16 .
  • Fluid control actuation element 15 may alternatively be located within fluid system 20 .
  • FIGS. 3-6 illustrate an exemplary embodiment of a delivery system incorporating a fluid system.
  • Pressure source 23 includes a gas cartridge, such as a CO2 cartridge, which is in fluid communication with fluid reservoir 21 , which in turn is in fluid communication with valve 38 , which functions as the fluid control actuation element.
  • gas cartridge such as a CO2 cartridge
  • valve 38 which functions as the fluid control actuation element.
  • delivery member actuation element 39 facilitates the reconfiguration of distal delivery region 14 from the delivery configuration shown in FIG. 4 to a procedural, or treatment, configuration shown in FIG. 5 .
  • Distal delivery region 14 comprises a plurality of expandable tubular elements 31 that are adapted to be reconfigured from respective delivery configuration as shown in FIG. 4 to expanded configurations shown in FIG. 5 .
  • the tubular elements are generally straight, and in substantial alignment with the longitudinal axis of the delivery member 13 .
  • Distal delivery region 14 is shown comprising four tubular elements 31 but any suitable number may be incorporated.
  • Tubular elements 31 may be sealed at their distal ends, and are secured to a distal portion of outer sheath 36 .
  • Tubular elements 31 include ports 35 in fluid communication with a fluid source. In the embodiments shown, the ports are formed by removing a portion of the tube wall proximal to the distal ends of tubular elements 31 .
  • the system includes control member 33 (see FIG.
  • Control member 33 is axially moveable with respect to the proximal portion of sheath 36 and is fixed to the sheath and tubular elements 31 distal to the distal delivery region.
  • control member 33 is actuated in the proximal direction, such as by actuation of delivery member actuation element 39 , the distal and proximal ends of tubular elements 31 are urged closer together, causing tubular elements 31 to bend at bending regions 34 radially outward from the control member.
  • the ports 35 are brought into contact, or at least pointed towards the lumen wall in which the distal delivery region is positioned.
  • Fluid or agent can then be delivered from the fluid source through ports 35 to disrupt the tissue, which is described in more detail above.
  • control member 33 is advanced distally with respect to the proximal portion of sheath 36 to move the ends of the tubular elements away from one another, reconfiguring the tubular elements back towards their delivery configurations.
  • ejection ports 35 are disposed in a plane substantially normal to that of the longitudinal axis of elongate delivery member 13 . More or fewer elongate tubes can be in the distal delivery regions.
  • the ports 35 can be staggered, which may be appropriate for different tissue disruption treatments.
  • Flexible tubes 31 may be fabricated from any suitable flexible materials, such as nitinol.
  • control member 33 has a lumen and thereby also provides the function of a guide wire lumen.
  • FIGS. 7-10 illustrate an exemplary method of remodeling of renal nerve plexus 43 surrounding renal artery 40 of kidney 44 using the exemplary system shown in FIGS. 3-6 .
  • the renal nerve plexus is depicted as two nerves for ease of representation, the renal nerve plexus actually wraps around the renal artery.
  • Elongate delivery member 13 with distal delivery region 14 is delivered from a femoral artery or other suitable location, using known techniques, to descending aorta 41 , then into renal artery 40 .
  • the delivery is facilitated by guidewire 17 which has been previously delivered by traditional means to the renal artery.
  • guidewire 17 which has been previously delivered by traditional means to the renal artery.
  • the delivery may be facilitated without the use of a guide wire.
  • the delivery may be facilitated by the use of a steerable introducer catheter such as those described in U.S. patent application Ser. No. 12/823,049, filed Jun. 24, 2009, the disclosure of which is incorporated herein by reference.
  • the distal delivery region 14 is expanded to a delivered configuration as shown in FIG. 8 by actuating the delivery member actuation element.
  • the actuation element is advanced distally.
  • the pressure source control element (see element 38 in FIG. 3 ) is activated thereby initiating the delivery of a dose configured as a high velocity jet of fluid 51 as indicated in FIG. 9 .
  • Single or multiple jets may be delivered while the distal deliver region is in any given location.
  • the distal delivery region may be moved to a new location by releasing (or further actuating) tissue expansion control element 12 (see FIG. 3 ), which reconfigures the distal delivery region.
  • the distal delivery region can then be moved to a second location, followed by actuation of the tissue interface expansion control element 12 .
  • the volume of tissue affected by the delivered fluid can be controlled by the volume of each individual fluid jet, the number of jets delivered at any given location, and the number and density of locations at which jets are delivered. After a desired number of jets are delivered to an appropriate number of locations, the action of the delivered fluid will affect a large enough volume of tissue to affect at least a portion of the renal nerve plexus, herein described as renal nerves, passing through the affected volumes of tissue and indicated in FIG. 10 . Any of the systems described herein can be used in the method shown in the exemplary method of FIGS. 7-10 .
  • FIGS. 11-19 illustrate various distal delivery regions 14 .
  • FIG. 11 represents a reconfigurable distal delivery region which is an extension of elongate delivery member 13 .
  • the distal delivery region comprises an elongate tubular element in a treatment, or expanded, configuration. In the delivery configuration (not shown), the elongate tubular element is in a substantially straight configuration.
  • the distal delivery region 14 substantially co-aligns with elongate delivery member 13 and upon exiting a delivery catheter assumes the configuration in FIG. 11 because of the resilient characteristics of the material.
  • the distal delivery region can be comprised of nitinol and utilize the superelastic property of nitinol to self-expand when deployed from a delivery catheter.
  • the elongate tubular element has a generally circular or elliptical configuration such that the contact region between the tubular element and the lumen wall falls roughly in a plane and has an elliptical or circular shape.
  • distal delivery region 14 also includes fluid control 16 , which includes at least one fluid jet aperture, discussed in more detail below.
  • fluid control 16 When distal delivery region 14 transfers from its delivery configuration to its procedural configuration, fluid control 16 is urged against the lumen wall of the target tissue. Distal delivery region 14 may be moved from position to position by allowing it to return to its delivery configuration or in some cases by moving it in its procedural configuration.
  • the tissue interface of FIG. 11 may alternatively be configured such that it is in a plane upon which the delivery axis exists.
  • Such a configuration may be comprised of a sinusoidal tissue interface incorporating one or more cycles of the sinusoid. Additionally each cycle or half cycle may fall on a different plane rotated from the previous one around the delivery axis.
  • FIG. 12 illustrates a distal delivery region including an elongate tubular element that has a spiral procedural configuration (as shown), such that the contact regions between the tissue and the tubular element have a spiral configuration.
  • the device in FIG. 12 is adapted to be actuated in similar manner to the device in 11 .
  • FIG. 13 illustrates a distal delivery region 14 including first and second tubular elements, which are adapted to be actuated in similar fashion to the device in FIG. 12 .
  • the elongate tubular elements in FIG. 13 have spiral configuration when expanded, and their contact regions with the target lumen are spiral.
  • the elongate tubular elements shown in FIGS. 12 and 13 include a plurality of fluid controls 16 .
  • FIG. 14 illustrates an exemplary portion of a distal delivery region.
  • Distal delivery region 14 is a variation of that of FIG. 12 , wherein the spiral element comprises two spring elements 18 arranged on either side of shuttle valve 50 incorporating a plurality of fluid controls 16 .
  • FIGS. 15 and 16 illustrate perspective and end views, respectively, of an alternative embodiment of the distal delivery region.
  • Distal delivery region 14 includes a tubular element with a general spiral treatment configuration, and includes a plurality of penetrating remodeling elements 19 .
  • Remodeling elements 19 can be used to remodel tissue in a number of different ways. Procedurally, the distal delivery region is delivered to a target lumen with penetrating remodeling elements 19 retracted with the distal delivery region in a delivery configuration. The elongate element is then reconfigured into a spiral configuration. Remodeling elements 19 , which were retracted during delivery, are then advanced distally through the elongate element into the configuration as shown in FIGS. 15 and 16 .
  • the remodeling elements may then be used to remodel the target tissue by any of mechanical damage resulting from high velocity jet interactions such as cutting or swelling and/or physical interaction of a cutting or macerating element, delivering a tissue disruption agent therethrough, delivering RF energy, or any combination thereof.
  • Penetrating remodeling elements 19 may comprise fluid controls as described below.
  • FIGS. 17 and 18 illustrate two variations on the distal delivery region shown in FIGS. 3-6 .
  • the distal delivery region control element 37 (which has a guide wire lumen therethrough) is retracted proximally relative to outer sheath 36 , which foreshortens the distal delivery region 14 .
  • each flexible tube incorporates needle valves including apertures 52 , as described herein.
  • valve control wires 64 extending through the fluid supply lines 65 .
  • the device of FIG. 18 expands in the same fashion, but comprises shuttle valves (described in more detail herein) rather than needle valves.
  • the exemplary alternative distal delivery region shown in FIG. 18 is shown incorporating four shuttle valves, each comprised of valve movable member 57 (see FIGS. 21 and 23 ), a valve stationary member 58 (see FIGS. 21 and 23 ), and a plurality of apertures 60 .
  • An alternate way to expand a distal delivery region is to incorporate a balloon.
  • FIGS. 19 and 20 show two exemplary distal delivery regions incorporating shuttle valves. Both embodiments comprise a balloon which is contoured to allow blood flow when the balloon is inflated. Blood flow is maintained in a spiral fluid path adjacent to the lumen contact zone comprising the shuttle valve.
  • fluid control 60 is a shuttle valve incorporated within the balloon 24 and in FIG. 20 fluid control 60 is a shuttle valve incorporated on the balloon.
  • These embodiments may alternatively comprise traditional non perfusion balloons.
  • the delivery devices described herein may be configured such that a single fluid control actuates a plurality of apertures 60 .
  • FIGS. 21-24 illustrate two variations on shuttle valves capable of being incorporated in a distal delivery region.
  • the valve of FIGS. 21 and 22 incorporates one or more apertures 52 on outer member 56 of the valve, and an inner member 55 , axially moveable with respect to outer member 56 , incorporating a masking aperture 53 .
  • Apertures 52 are smaller than masking aperture 53 .
  • An individual aperture 52 is selectively addressed when the sliding inner masking aperture 53 is slid into a position adjacent aperture 52 .
  • members 55 and 56 are sealed at their distal ends 57 and 58 respectively.
  • the member adapted to be moved with respect to the other member may be left open when the design is such that the length of tubing distal to masking aperture 53 is long enough to cover all of apertures 52 distal to the addressed aperture.
  • Inner member 55 and outer member 56 are configured such that the outer diameter of the inner member and the inner diameter of the outer member are closely matched thereby creating an annular region of minimum cross section and high fluid resistance.
  • the inner movable member or sections thereof may be designed such that under the loads experienced while pressurized it expands and thereby decreases the annular cross section thereby further increasing the fluid resistance.
  • valves may be selectively addressable in series. That is, as aperture 53 is moved from a first aperture 52 to a second aperture 52 , the first and second apertures are selectively addressed in series.
  • the movable member 53 when movable member 53 is allowed a rotational degree of freedom around the axis defined by its central lumen, the movable member 53 may be rotated 90 degrees and moved past smaller apertures 52 without addressing them, then rotated 90 degrees in the reverse direction when aligned with the aperture intended to be addressed.
  • FIGS. 23 and 24 depict an alternative variation on a shuttle valve wherein masking aperture 53 is located on outer stationary member 56 and aperture 52 is located on inner movable member 55 .
  • Masking aperture 53 can be used to an additional advantage as a mask that creates a field of view 54 addressable by inner aperture 52 .
  • the aperture 52 may be rotated about the cylindrical axis of the outer stationary member 56 within the mask forming a field of view 54 .
  • the field of view 54 forms the core of the remodeled volume of damaged tissue peripheral to the lumen.
  • the field of view 54 may alternatively describe a slice in the tissue resulting from the jet interaction with the tissue.
  • the fields of views illustrated in FIGS. 23 and 24 illustrate exemplary patterns in which tissue is cut or severed by the tissue remodeling therapies described herein.
  • the apertures 52 described herein can fall within a range of diameters, or surface areas when not circular in cross section.
  • diameters of about 0.005 in to about 0.0005 in will be of particular value.
  • the aperture should be sized such that the peak velocity of the outflow reaches a minimum of about 10 m/sec, with about 75 to about 150 m/sec being more optimal for greater penetration and minimizing erosion. In some situations velocities of greater than about 150 m/sec will be useful in achieving even greater penetration.
  • the tissue interface means described herein provide for a means of stabilizing the fluid apertures in contact with tissue in a manner that minimizes movement of the aperture relative to the adjacent tissue. The risk of dissections associated with the use of fluid jets is thereby minimized. Additionally, by incorporating of distal fluid controls, the period over which agents are delivered can be controlled. By providing jets of agent in short bursts of 1 second or less, preferably 100 msec or less, unexpected movements will result in multiple punctate wounds as opposed to a linear dissection.
  • FIG. 25 illustrates the spiraled distal delivery region from FIG. 12 incorporated with a shuttle valve design from FIG. 23 , and expanded in renal artery 40 .
  • the pattern of tissue damage is indicated by fields of view 54 .
  • FIG. 26 illustrates a view normal to the direction of blood flow demonstrating how the projection of such patterns normal to the axis of the lumen can produce both dense and overlapping coverage further from the lumen and spaced non-overlapping coverage closer to the lumen.
  • the density of jetting structures and associated fields of view may be increased to a point where the remodeled zones themselves overlap.
  • the associated density and field of view required will be dependent on the particular way in which the damage is created.
  • the ratio of the volume of damaged tissue close to the aperture, seeded by the field of view 54 can be minimized relative to volume of damage further away.
  • the aperture's field of view 54 may be increased to correspondingly increase the damage at the tunica media 47 .
  • any of the fields of view indicated may be addressed in any sequence by appropriately controlling the movable member of shuttle valve 23 . In this way more or less of the renal nerve may be disrupted.
  • the devices of FIGS. 21 and 23 may be configured such that only a single fluid control may be addressed at one time or such that multiple fluid controls may be addressed at one time.
  • FIGS. 27-32 illustrate various configurations and aspects of exemplary needle valves that can be activated from the proximal end of the delivery system, allow for minimal leakage in a closed configuration or high fluid resistance when not activated, allow minimal fluid resistance in an open configuration, provide the ability to provide a metered dose from the valve, and are capable of both serial or parallel activation. All valves are activated by a valve control member 64 , which is adapted to be axially moved (forward and back) within fluid supply section 65 , both of which terminate in a handle (not shown). In some instances there is also a metering or delivery section 66 .
  • a valve control member 64 which is adapted to be axially moved (forward and back) within fluid supply section 65 , both of which terminate in a handle (not shown).
  • a metering or delivery section 66 In some instances there is also a metering or delivery section 66 .
  • the needle valve is supplied by a pressurized fluid source maintained at relatively constant pressure which is in fluid communication with the aperture 52 via supply section 65 , within which is valve control element 64 .
  • a pressurized fluid source maintained at relatively constant pressure which is in fluid communication with the aperture 52 via supply section 65 , within which is valve control element 64 .
  • valve control element 64 In any cross section within which valve control member 64 is contained within the fluid supply section, there is a relatively non-restrictive fluid flow cross section, shown in FIG. 27 as annular region 63 .
  • delivery valve section 66 Distal to the fluid supply section is delivery valve section 66 , which in the embodiment of FIGS. 27-29 is of smaller diameter than the supply section.
  • needle element 61 which is disposed within delivery section 66 .
  • the clearance between the needle and delivery section lumen is small, such that it forms a narrow restrictive annular region of relatively high fluid resistance 62 as compared to that of the lumen with the needle removed.
  • the fluid flow cross section of supply section 62 is much smaller than 63. For instance, for a particular concentration of ETOH and water, a restrictive fluid flow cross section created by a 0.5 inch long 0.004 inch inner diameter needle in a 0.005 inch inner diameter tube will have a fluid resistance of 450 psi/mL/min. The corresponding resistance for the same tube without the needle will be approximately 5 psi/mL/min.
  • a supply section created by a 32 inch long tube with a 0.015 inch outer diameter and a 0.010 inch outer diameter control wire will have a corresponding fluid resistance of approximately 1 psi/mL/min.
  • the fluid resistance of the system in the open configuration is approximately 75 times less than that of the closed system, and in a constant pressure environment would leak at a rate of about 1/75 the open rate in the closed configuration.
  • an aperture 52 is created on the side of delivery section 66 near the sealed distal end.
  • the aperture is the open distal end of the delivery section.
  • FIG. 30 shows a needle valve in an open configuration where the end of the needle is maintained just within the lumen of the delivery section 66 .
  • the valve is partially closed with a section of a restrictive fluid flow cross section 62 indicated.
  • FIG. 32 shows the valve fully closed with the distal face of the guide 69 seated against the proximal face of the end seal of the supply section 65 . If required, further increases in fluid resistance can be attained in the fully closed position by incorporating an elastomeric guide 69 or an elastomeric distal face to guide 69 which would seal against the proximal face of the end seal on the supply section 65 .
  • Guide 69 additionally incorporates relieved areas to create a large fluid flow cross section 63 .
  • FIGS. 33-35 illustrate an exemplary embodiment of a metering valve configuration.
  • Guide 69 is configured such that it forms a narrow restrictive annular aperture with the end of the delivery section 66 , which in this configuration may be the end of the supply section 65 .
  • the valve control member 64 When the valve control member 64 is actuated proximally, fluid leaks across the restrictive fluid flow cross section 62 , filling the distal metered volume 67 . At this point the fluid resistance between the supply side and the delivery side is the sum of that associated with the exit aperture 52 and the restrictive cross section 62 .
  • the valve control member 64 is released the resistance associated with fluid flow across cross section 62 goes to zero and the guide moves as a plug of delivery fluid.
  • the movement of the guide imparts minimal additional fluid resistance to the system, thereby allowing the pressure across aperture 52 to attain levels comparable to those seen with no guide in place.
  • This state remains in effect until the guide runs into the distal sealed end 68 of the delivery section 66 , as shown in FIG. 35 .
  • the outflow resistance becomes that associated with the restrictive fluid flow cross section 62 and aperture 52 again.
  • the delivered volume that volume delivered under high pressure and at high velocity which penetrates the intima—is that which was disposed distal to the guide plug prior to its release.
  • the delivered volume can therefore be regulated and controlled, and can be adjustable.
  • the rate at which the guide is withdrawn during the fill cycle can be matched to that of the expected fluid flow across restrictive fluid flow cross section 62 such that there is minimal negative pressure generated across the guide 69 .
  • This configuration behaves differently than other control elements in that the fluid resistance across the control element remains constant but the position of the control element is allowed to change.
  • the travel of the guide 69 is defined by the amount of proximal displacement of the guide from the distal end seal 68 which acts as its stop.
  • the displacement of the guide 69 may be controlled by alternate mechanisms and the guides displacement may terminate proximal to the end seal 68 .
  • FIGS. 36 and 37 illustrate the distal delivery region of FIGS. 15 and 16 deployed within a section of renal artery 40 .
  • the end of elongate delivery member 13 just distal to distal delivery region 14 can be seen centered in the vessel.
  • Penetrating remodeling elements 19 have been deployed from their non-deployed configuration within the distal delivery region to their deployed state, penetrating through intimal 46 and medial layer 47 of the vessel and terminating in the adventitial layer 48 .
  • Volumes of remodeled tissue 45 spiral through the adventitia, with one intersecting nerve 43 .
  • FIG. 37 depicts a view normal to the axis of blood flow for the vessel in which can be seen that the primary volume of remodeled tissue occurs beyond the intimal and adventitial layers.
  • a penetrating remodeling element 19 is a needle.
  • the needle has a helical configuration and delivered while contained with an outer sheath of a delivery section 13 of a delivery system, not shown.
  • the outer sheath of the delivery section has a stiffness sufficient to maintain the spring element in a straightened configuration.
  • the remodeling element is pushed distally out of the distal end of the outer sheath of the delivery system until the distal end of the remodeling element has passed into the vessel wall.
  • the remodeling element is then twisted, which in combination with the pre-set spiral configuration allows the remodeling element 16 to screw its way around the vessel within the adventitial layer.
  • the remodeling element can be comprised of a number of different configurations.
  • the remodeling element may additionally be porous such that an ablating agent (described herein) may be delivered through the porous structure. It may alternatively be coated with an ablative agent. In those embodiments where it is used to deliver an ablative agent on or through its walls and it is conductive the electroporative capability may be used to enhance the action of the ablative compound delivered.
  • the remodeling element When the remodeling element is comprised of a needle, it may also be used to leave an ablative element in the tract of its path as the element is removed by a procedure in reverse of that by which it was delivered.
  • the material left may alternatively be one designed to absorb energy provided by an external source such as a gel containing a ferrite as mentioned elsewhere in this application.
  • the pressure may be adjusted between delivery cycles. In this manner the volume and spatial characteristics of the remodeled tissue volume may be adjusted.
  • imaging means include but are not limited to CT, MRI, and ultrasound.
  • FIG. 42 provides a figurative representation of a delivery system incorporating a distal fluid control configured as a shuttle valve, while a representation of its fluidic performance is illustrated in FIG. 39 .
  • the system comprises a fluid and pressure source 20 , which feeds a delivery system 10 , as generally described above.
  • the delivery system is comprised of elongate delivery member 13 comprising a fluid supply section feeding into distal delivery region 14 , which comprises a fluid control terminating in aperture 52 from which a jet of fluid 51 is ejected under appropriate conditions of alignment.
  • FIG. 40 is a figurative representation of the delivery system in terms of its resistive fluidic characteristics.
  • the elements are the fluid resistance of the fluid source 83 contained within elongate delivery member 13 , the fluid resistance of the fluid path within the tissue interface portion 84 , and the fluid resistance of control port 80 . Each of these elements has an associated capacitance which is not shown in this representation.
  • the control port behaves as a variable resistance which is the primary characteristic under control.
  • FIGS. 40 and 41 illustrate various aspects of the resistive fluidic performance of these components.
  • FIG. 40 represents the resistance associated with the fluid control port 80 , as a function of the displacement “d” of its control element position, and the resistances for the supply section and tissue interface portions of the system 83 and 84 respectively, which are not directly controllable in this configuration and are essentially fixed.
  • the point “0” corresponds to the position where the proximal edge of the jet exit aperture aligns with the proximal edge of the jet masking aperture.
  • the position “a” corresponds to the point at which the distal edge of the jet aperture aligns with the distal edge of the masking aperture, and b represents a point where the proximal edge of the jet exit aperture is distal to the distal edge of the jet masking aperture by some distance a-b.
  • the fluid resistance versus displacement characteristics of the shuttle valve fluid control 80 has two distinct performance features.
  • FIG. 41 illustrates a representation of the expected outflow rate 90 as a function d given the resistance characteristics represented in FIG. 40 and a constant pressure supply.
  • Outflow rate 90 is comprised of a high constant rate of outflow 91 for displacements “0” to “a” and a decreasing rate of outflow 92 for displacements “a” to “b”.
  • the regions represented by displacements “0” to “a” correspond to the on state and the displacement “b” correspond to the off state.
  • the system resistance will be the sum of the component resistances.
  • the scales indicated should be understood as arbitrary and the magnitude of the difference in flow and resistance in the off state versus the on state may be a few times to multiple orders of magnitude.
  • FIG. 43 shows the system of FIG. 39 wherein the shuttle valve is replaced by a needle valve.
  • This system demonstrates fluidic behavior similarly to that described for the shuttle valve variation.
  • certain differences associated with actuation and fabrication are notable and delineated below.
  • the shuttle valve based system may be configured such that control elements are comprised of two parts as is illustrated in FIGS. 21-24 above.
  • the needle valve and metered valve variations by contrast require a separate control element and associated controllable member for each valve separately addressable.
  • the variable resistance associated with the control element 80 is shifted to the position of the tissue interface 84 , the resistance of the tissue interface and the jet exit apertures in the most distal position.
  • Such an arrangement does not lend itself to a serial arrangement as the multiple valves require a common source which is proximal to the control element.
  • the ability to serially and or individually address each fluid control has particular value where uniformity of delivery is required.
  • an individual device may be calibrated in such a fashion that the outflow resistance for each outflow is known and used to adjust the either or both the static source pressure or the on time such that each outflow behaves similarly with reference to the fluid delivery during an injection cycle.
  • the fluid media delivered may contain a contrast agent and the operator can use the visual information to change the source pressure to vary depth of penetration, duration of injection to adjust volume delivered, or provide multiple injection cycles at a given location to adjust volume of targeted tissue.
  • the delivery cycle may additionally be spread out over time such that an initial volume is injected at an initial time, then an additional volume is injected at a later time where enough time is allowed such that information on the rate of diffusion of the delivered fluid is gained and additional volumes may then be delivered in a fashion wherein the a concentration of ablatant sufficient to ablate is maintained in the remodeled target volume for a sufficient time to remodel the tissue.
  • FIG. 44 represents yet another alternative for effecting tissue remodeling where a fluid, gas, or mechanical rod may be used to eject a component capable of external excitation as described herein or alternatively a component which upon ejection springs into a shape different than its delivery shape and in so doing damages tissue in its vicinity, thereby causing tissue remodeling.
  • spring elements 101 are shown after ejection from distal delivery region 30 through the wall of renal artery 40 . As shown, multiple spring elements 101 have been ejected from two separate positions of distal delivery region 30 .
  • Spring elements 101 may be configured such that the tines are held together for a period of time past the ejection cycle. For instance they may be held together by a water soluble binder and injected in a gas, oil, or alcohol carrier. In this fashion, on residing within the tissue for a period of time the binder will be solubalized and the tines released. The release of the tines may be used to cut or macerate the tissue surrounding the tines.
  • the volume of tissue affected by a needleless injection will be dependent on the spatial velocity and temporal velocity profiles of the injectate at the time of delivery.
  • delivering a volume of fluid into a tissue mass at high initial velocity minimizes tissue damage at the entry point while allowing fluid to penetrate deep into the tissue. Maintaining the outflow at a lower velocity after the initial penetration facilitates an increase in volume delivered through the initial wound.
  • the control mechanism has been incorporated at the distal region of the delivery system. This allows the delivery system to be maintained at delivery pressures and thereby minimizes the filtering effects of the long narrow delivery lumens and system capacitance on the velocity profile of ejected fluid at the exit aperture.
  • tissue remodeling device cutting or macerating devices may be delivered through or in the manner that needles 16 in FIGS. 36 and 37 are delivered.
  • Such devices may be configured as slicing hooks or simple blades which cut on being pushed as represented in FIG. 45 . Additionally such devices may be spun as an atherectomy blade to facilitate the requisite remodeling as depicted in FIG. 46 through which the rotatable cutting device of FIG. 45 is delivered.
  • FIG. 47 shows a device as in FIG. 36 . While preferred embodiments of the present disclosure have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the disclosure. It should be understood that various alternatives to the embodiments of the disclosure described herein may be employed in practicing the disclosure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
US13/071,436 2010-03-24 2011-03-24 Intravascular tissue disruption Active 2032-01-31 US8840601B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US13/071,436 US8840601B2 (en) 2010-03-24 2011-03-24 Intravascular tissue disruption
US13/351,962 US20120116438A1 (en) 2010-03-24 2012-01-17 Intravascular Tissue Disruption
US13/748,374 US20130138082A1 (en) 2010-03-24 2013-01-23 Intravascular Tissue Disruption
US15/092,442 US20170080184A1 (en) 2010-03-24 2016-04-06 Intravascular tissue disruption
US15/167,509 US20170027601A1 (en) 2010-03-24 2016-05-27 Intravascular tissue disruption

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31723110P 2010-03-24 2010-03-24
US32446110P 2010-04-15 2010-04-15
US13/071,436 US8840601B2 (en) 2010-03-24 2011-03-24 Intravascular tissue disruption

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/351,962 Continuation US20120116438A1 (en) 2010-03-24 2012-01-17 Intravascular Tissue Disruption
US13/748,374 Continuation-In-Part US20130138082A1 (en) 2010-03-24 2013-01-23 Intravascular Tissue Disruption

Publications (2)

Publication Number Publication Date
US20110257622A1 US20110257622A1 (en) 2011-10-20
US8840601B2 true US8840601B2 (en) 2014-09-23

Family

ID=44673869

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/071,436 Active 2032-01-31 US8840601B2 (en) 2010-03-24 2011-03-24 Intravascular tissue disruption
US13/351,962 Abandoned US20120116438A1 (en) 2010-03-24 2012-01-17 Intravascular Tissue Disruption
US15/092,442 Abandoned US20170080184A1 (en) 2010-03-24 2016-04-06 Intravascular tissue disruption

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/351,962 Abandoned US20120116438A1 (en) 2010-03-24 2012-01-17 Intravascular Tissue Disruption
US15/092,442 Abandoned US20170080184A1 (en) 2010-03-24 2016-04-06 Intravascular tissue disruption

Country Status (7)

Country Link
US (3) US8840601B2 (es)
EP (1) EP2550040A4 (es)
JP (1) JP2013521995A (es)
CN (1) CN102917748B (es)
AU (3) AU2011232335A1 (es)
CA (1) CA2793737A1 (es)
WO (1) WO2011119857A2 (es)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9333031B2 (en) 2013-04-08 2016-05-10 Apama Medical, Inc. Visualization inside an expandable medical device
US9586025B2 (en) 2009-06-24 2017-03-07 Shifamed Holdings, Llc Steerable delivery sheaths
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
US10349824B2 (en) 2013-04-08 2019-07-16 Apama Medical, Inc. Tissue mapping and visualization systems
US10420537B2 (en) 2015-03-27 2019-09-24 Shifamed Holdings, Llc Steerable medical devices, systems, and methods of use
US10736693B2 (en) 2015-11-16 2020-08-11 Apama Medical, Inc. Energy delivery devices
US10933221B2 (en) 2015-11-09 2021-03-02 Kalila Medical, Inc. Steering assemblies for medical devices, and methods of use
US11052226B2 (en) 2015-04-24 2021-07-06 Kalila Medical, Inc. Steerable medical devices, systems, and methods of use
US11382689B2 (en) 2012-11-02 2022-07-12 Neurotronic, Inc. Chemical ablation formulations and methods of treatments for various diseases
US11517725B2 (en) * 2012-11-02 2022-12-06 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
US11529497B1 (en) 2022-01-13 2022-12-20 Orlando Health, Inc. Centering device for a catheter
US12082868B2 (en) 2012-11-13 2024-09-10 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
CA2938411C (en) 2003-09-12 2019-03-05 Minnow Medical, Llc Selectable eccentric remodeling and/or ablation of atherosclerotic material
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US7803168B2 (en) 2004-12-09 2010-09-28 The Foundry, Llc Aortic valve repair
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
EP2076193A4 (en) 2006-10-18 2010-02-03 Minnow Medical Inc MATCHED RF-ENERGY AND ELECTRO-TISSUE CHARACTERIZATION FOR THE SELECTIVE TREATMENT OF TARGET TISSUE
AU2007310986B2 (en) 2006-10-18 2013-07-04 Boston Scientific Scimed, Inc. Inducing desirable temperature effects on body tissue
EP2455034B1 (en) 2006-10-18 2017-07-19 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
CN102271603A (zh) 2008-11-17 2011-12-07 明诺医学股份有限公司 得知或未得知组织形态的选择性能量积累
AU2010266027B2 (en) * 2009-06-24 2015-05-07 Shifamed Holdings, Llc Steerable medical delivery devices and methods of use
WO2011056684A2 (en) 2009-10-27 2011-05-12 Innovative Pulmonary Solutions, Inc. Delivery devices with coolable energy emitting assemblies
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
KR20130108067A (ko) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 조직 치료를 위한 발전 및 제어 장치
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
WO2011143468A2 (en) 2010-05-12 2011-11-17 Shifamed, Llc Low profile electrode assembly
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
CN202654229U (zh) 2010-10-25 2013-01-09 美敦力Af卢森堡有限责任公司 用于通过肾去神经支配治疗人类患者的导管装置
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
CN103517731B (zh) 2011-04-08 2016-08-31 柯惠有限合伙公司 用于去除肾交感神经和离子电渗式药物传递的离子电渗式药物传递系统和方法
US9237925B2 (en) 2011-04-22 2016-01-19 Ablative Solutions, Inc. Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation
US8663190B2 (en) 2011-04-22 2014-03-04 Ablative Solutions, Inc. Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation
CN103930061B (zh) 2011-04-25 2016-09-14 美敦力阿迪安卢森堡有限责任公司 用于限制导管壁低温消融的有关低温球囊限制部署的装置及方法
WO2013013156A2 (en) 2011-07-20 2013-01-24 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
JP6106669B2 (ja) 2011-07-22 2017-04-05 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． ヘリカル・ガイド内に配置可能な神経調節要素を有する神経調節システム
US9056185B2 (en) 2011-08-24 2015-06-16 Ablative Solutions, Inc. Expandable catheter system for fluid injection into and deep to the wall of a blood vessel
US9278196B2 (en) 2011-08-24 2016-03-08 Ablative Solutions, Inc. Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation
US20130053792A1 (en) 2011-08-24 2013-02-28 Ablative Solutions, Inc. Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation
WO2013055826A1 (en) 2011-10-10 2013-04-18 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
WO2013055815A1 (en) 2011-10-11 2013-04-18 Boston Scientific Scimed, Inc. Off -wall electrode device for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013058962A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Deflectable medical devices
US9079000B2 (en) 2011-10-18 2015-07-14 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
CN108095821B (zh) 2011-11-08 2021-05-25 波士顿科学西美德公司 孔部肾神经消融
EP2779929A1 (en) 2011-11-15 2014-09-24 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
CA2859989C (en) 2011-12-23 2020-03-24 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
CN104135958B (zh) 2011-12-28 2017-05-03 波士顿科学西美德公司 用有聚合物消融元件的新消融导管调变神经的装置和方法
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
EP2806920A4 (en) * 2012-01-23 2015-08-05 Shifamed Holdings Llc BREAKAGE OF INTRAVASCULAR TISSUE
US10029076B2 (en) 2012-02-28 2018-07-24 Covidien Lp Intravascular guidewire
US8961550B2 (en) 2012-04-17 2015-02-24 Indian Wells Medical, Inc. Steerable endoluminal punch
US10660703B2 (en) 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
CN107157576B (zh) 2012-05-11 2019-11-26 美敦力Af卢森堡有限责任公司 用于人类患者的处理的肾神经调节系统
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
US8612022B1 (en) 2012-09-13 2013-12-17 Invatec S.P.A. Neuromodulation catheters and associated systems and methods
CN104780859B (zh) 2012-09-17 2017-07-25 波士顿科学西美德公司 用于肾神经调节的自定位电极系统及方法
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
JP6074051B2 (ja) 2012-10-10 2017-02-01 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 血管内神経変調システム及び医療用デバイス
US8740849B1 (en) 2012-10-29 2014-06-03 Ablative Solutions, Inc. Peri-vascular tissue ablation catheter with support structures
US10226278B2 (en) 2012-10-29 2019-03-12 Ablative Solutions, Inc. Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures
US9554849B2 (en) 2012-10-29 2017-01-31 Ablative Solutions, Inc. Transvascular method of treating hypertension
US10736656B2 (en) 2012-10-29 2020-08-11 Ablative Solutions Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures
US9526827B2 (en) 2012-10-29 2016-12-27 Ablative Solutions, Inc. Peri-vascular tissue ablation catheter with support structures
US10945787B2 (en) 2012-10-29 2021-03-16 Ablative Solutions, Inc. Peri-vascular tissue ablation catheters
US9301795B2 (en) 2012-10-29 2016-04-05 Ablative Solutions, Inc. Transvascular catheter for extravascular delivery
US10881458B2 (en) 2012-10-29 2021-01-05 Ablative Solutions, Inc. Peri-vascular tissue ablation catheters
CN104902920A (zh) 2012-12-21 2015-09-09 赛诺菲 作为glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂的毒蜥外泌肽-4衍生物
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9956033B2 (en) 2013-03-11 2018-05-01 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9108019B2 (en) * 2013-03-13 2015-08-18 Boston Scientific Limited Catheter system
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9297845B2 (en) 2013-03-15 2016-03-29 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
US10022182B2 (en) 2013-06-21 2018-07-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
CN105473091B (zh) 2013-06-21 2020-01-21 波士顿科学国际有限公司 具有可一起移动的电极支撑件的肾脏去神经球囊导管
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
US9833283B2 (en) 2013-07-01 2017-12-05 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
WO2015006480A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US9925001B2 (en) 2013-07-19 2018-03-27 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
JP2016527959A (ja) 2013-07-22 2016-09-15 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 腎神経アブレーション用医療器具
EP3024405A1 (en) * 2013-07-22 2016-06-01 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
WO2015027096A1 (en) 2013-08-22 2015-02-26 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
US9895194B2 (en) 2013-09-04 2018-02-20 Boston Scientific Scimed, Inc. Radio frequency (RF) balloon catheter having flushing and cooling capability
US20150073515A1 (en) 2013-09-09 2015-03-12 Medtronic Ardian Luxembourg S.a.r.I. Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
EP3043733A1 (en) 2013-09-13 2016-07-20 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
EP3057488B1 (en) 2013-10-14 2018-05-16 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
AU2014334574B2 (en) 2013-10-15 2017-07-06 Boston Scientific Scimed, Inc. Medical device balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636538B (zh) 2013-10-18 2019-01-15 波士顿科学国际有限公司 具有柔性导线的球囊导管及其使用和制造的相关方法
US9949652B2 (en) 2013-10-25 2018-04-24 Ablative Solutions, Inc. Apparatus for effective ablation and nerve sensing associated with denervation
US9931046B2 (en) 2013-10-25 2018-04-03 Ablative Solutions, Inc. Intravascular catheter with peri-vascular nerve activity sensors
US10517666B2 (en) 2013-10-25 2019-12-31 Ablative Solutions, Inc. Apparatus for effective ablation and nerve sensing associated with denervation
JP2016534842A (ja) 2013-10-25 2016-11-10 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 除神経フレックス回路における埋め込み熱電対
US9877742B2 (en) 2013-11-14 2018-01-30 Cook Medical Technologies Llc Thrombectomy catheter with flow directing mechanism
JP6382989B2 (ja) 2014-01-06 2018-08-29 ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． 耐引き裂き性フレキシブル回路アセンブリを備える医療デバイス
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
US9907609B2 (en) 2014-02-04 2018-03-06 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US10736690B2 (en) 2014-04-24 2020-08-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters and associated systems and methods
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US11058819B2 (en) * 2015-11-27 2021-07-13 Sanofi-Aventis Deutschland Gmbh Auto-injector device
WO2018226991A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US10857020B2 (en) 2017-09-14 2020-12-08 Olympus Corporation Gastrointestinal track constricting method
CN111556763B (zh) * 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
US11116561B2 (en) 2018-01-24 2021-09-14 Medtronic Ardian Luxembourg S.A.R.L. Devices, agents, and associated methods for selective modulation of renal nerves
EP4085965A1 (en) 2018-02-01 2022-11-09 Shifamed Holdings, LLC Intravascular blood pumps and methods of use and manufacture
US10561489B2 (en) 2018-03-05 2020-02-18 Olympus Corporation Gastrointestinal-tract constricting method
US10555801B2 (en) 2018-03-05 2020-02-11 Olympus Corporation Gastrointestinal-tract constricting method
US10918454B2 (en) * 2018-04-02 2021-02-16 Olympus Corporation Gastrointestinal tract constricting method
US10849685B2 (en) 2018-07-18 2020-12-01 Ablative Solutions, Inc. Peri-vascular tissue access catheter with locking handle
WO2020150623A1 (en) * 2019-01-18 2020-07-23 University Of Georgia Research Foundation, Inc. Salt nanoparticles and compositions and methods of use thereof
JP2022540616A (ja) 2019-07-12 2022-09-16 シファメド・ホールディングス・エルエルシー 血管内血液ポンプならびに製造および使用の方法
US11654275B2 (en) 2019-07-22 2023-05-23 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC INTRAVASCULAR BLOOD PUMP SYSTEMS AND METHODS OF USE AND CONTROL THEREOF
WO2021062270A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Catheter blood pumps and collapsible pump housings

Citations (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547193A (en) 1984-04-05 1985-10-15 Angiomedics Incorporated Catheter having embedded multi-apertured film
US4634432A (en) 1985-05-13 1987-01-06 Nuri Kocak Introducer sheath assembly
US4692139A (en) 1984-03-09 1987-09-08 Stiles Frank B Catheter for effecting removal of obstructions from a biological duct
US4726382A (en) 1986-09-17 1988-02-23 The Boc Group, Inc. Inflatable finger cuff
US4890623A (en) 1988-03-14 1990-01-02 C. R. Bard, Inc. Biopotential sensing device and method for making
US4968306A (en) * 1989-07-07 1990-11-06 Advanced Cardiovascular Systems, Inc. Intravascular catheter having an adjustable length infusion section to delivery therapeutic fluid
US5010895A (en) 1989-08-03 1991-04-30 Empi, Inc. Expandable vaginal electrode
DE4104092A1 (de) 1990-02-13 1991-08-14 Christoph Dr Med Rieger Von einem flexiblen kunststoffschlauch ueberzogene metallkanuele
US5041089A (en) 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
US5069674A (en) 1988-11-23 1991-12-03 Medical Engineering And Development Institute, Inc. Flexible, kink-resistant catheter
US5180376A (en) 1990-05-01 1993-01-19 Cathco, Inc. Non-buckling thin-walled sheath for the percutaneous insertion of intraluminal catheters
US5209741A (en) 1991-07-08 1993-05-11 Endomedix Corporation Surgical access device having variable post-insertion cross-sectional geometry
US5213576A (en) * 1991-06-11 1993-05-25 Cordis Corporation Therapeutic porous balloon catheter
US5228442A (en) 1991-02-15 1993-07-20 Cardiac Pathways Corporation Method for mapping, ablation, and stimulation using an endocardial catheter
US5306250A (en) * 1992-04-02 1994-04-26 Indiana University Foundation Method and apparatus for intravascular drug delivery
US5309910A (en) 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5311866A (en) 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
US5343860A (en) 1989-02-06 1994-09-06 Arzco Medical Systems, Inc. Esophageal recording/pacing catheter with thermistor and cardiac imaging transceiver
US5391200A (en) 1992-09-30 1995-02-21 Cardiac Pacemakers, Inc. Defibrillation patch electrode having conductor-free resilient zone for minimally invasive deployment
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5496267A (en) * 1990-11-08 1996-03-05 Possis Medical, Inc. Asymmetric water jet atherectomy
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5515848A (en) 1991-10-22 1996-05-14 Pi Medical Corporation Implantable microelectrode
US5531679A (en) * 1994-03-14 1996-07-02 Schulman; Joseph H. Fluidic infusion system for catheter or probe
US5540679A (en) 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US5562720A (en) 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5571086A (en) * 1992-11-02 1996-11-05 Localmed, Inc. Method and apparatus for sequentially performing multiple intraluminal procedures
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
US5573520A (en) 1991-09-05 1996-11-12 Mayo Foundation For Medical Education And Research Flexible tubular device for use in medical applications
US5575788A (en) 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5609606A (en) 1993-02-05 1997-03-11 Joe W. & Dorothy Dorsett Brown Foundation Ultrasonic angioplasty balloon catheter
US5626564A (en) * 1995-03-31 1997-05-06 Creighton University Adjustable sideholes catheter
US5630837A (en) 1993-07-01 1997-05-20 Boston Scientific Corporation Acoustic ablation
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5715825A (en) 1988-03-21 1998-02-10 Boston Scientific Corporation Acoustic imaging catheter and the like
US5718701A (en) 1993-08-11 1998-02-17 Electro-Catheter Corporation Ablation electrode
EP0637943B1 (en) 1992-05-01 1998-04-01 Vesta Medical, Inc. Endometrial ablation apparatus
US5735846A (en) 1994-06-27 1998-04-07 Ep Technologies, Inc. Systems and methods for ablating body tissue using predicted maximum tissue temperature
US5779698A (en) 1989-01-18 1998-07-14 Applied Medical Resources Corporation Angioplasty catheter system and method for making same
US5792118A (en) 1994-03-07 1998-08-11 Kurth; Paul A. Permanent catheter with an exterior balloon valve and method of using the same
US5800408A (en) * 1996-11-08 1998-09-01 Micro Therapeutics, Inc. Infusion device for distributing infusate along an elongated infusion segment
US5836874A (en) 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5846196A (en) 1995-12-13 1998-12-08 Cordis Europa N.V. Intravascular multielectrode cardiac mapping probe
US5846239A (en) 1996-04-12 1998-12-08 Ep Technologies, Inc. Tissue heating and ablation systems and methods using segmented porous electrode structures
US5846238A (en) 1996-01-19 1998-12-08 Ep Technologies, Inc. Expandable-collapsible electrode structures with distal end steering or manipulation
US5853411A (en) 1996-01-19 1998-12-29 Ep Technologies, Inc. Enhanced electrical connections for electrode structures
WO1999000060A1 (en) 1997-06-26 1999-01-07 Advanced Coronary Intervention Electrosurgical catheter for resolving obstructions by radio frequency ablation
US5860974A (en) 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5871483A (en) 1996-01-19 1999-02-16 Ep Technologies, Inc. Folding electrode structures
US5879348A (en) 1996-04-12 1999-03-09 Ep Technologies, Inc. Electrode structures formed from flexible, porous, or woven materials
US5882332A (en) 1997-06-06 1999-03-16 Wijay; Bandula Drug infusion catheter and method
US5888577A (en) 1997-06-30 1999-03-30 Procath Corporation Method for forming an electrophysiology catheter
US5904651A (en) 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
WO1999048545A1 (en) 1998-03-25 1999-09-30 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US5961513A (en) 1996-01-19 1999-10-05 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures
US5991650A (en) 1993-10-15 1999-11-23 Ep Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
US6004269A (en) 1993-07-01 1999-12-21 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
WO2000066014A1 (en) 1999-04-29 2000-11-09 Somnus Medical Technologies, Inc. Device for the ablation of tissue
US6163726A (en) 1998-09-21 2000-12-19 The General Hospital Corporation Selective ablation of glandular tissue
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6206912B1 (en) 1996-11-07 2001-03-27 St. Jude Medical Anastomotic Technology Group Inc. Medical grafting methods and apparatus
US6292689B1 (en) 1996-04-17 2001-09-18 Imagyn Medical Technologies California, Inc. Apparatus and methods of bioelectrical impedance analysis of blood flow
US20020002384A1 (en) 1997-11-07 2002-01-03 Paul Gilson Embolic protection device
US6402746B1 (en) 1996-12-19 2002-06-11 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US20020095147A1 (en) 2000-08-16 2002-07-18 Shadduck John H. Electrical discharge catheter system for extracting emboli in endovascular interventions
US6460545B2 (en) 1993-03-16 2002-10-08 Ep Technologies, Inc. Medical device with three dimensional collapsible basket structure
US6471683B2 (en) * 1990-08-06 2002-10-29 Possis Medical, Inc. Thrombectomy and tissue removal method
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6558378B2 (en) 1998-05-05 2003-05-06 Cardiac Pacemakers, Inc. RF ablation system and method having automatic temperature control
US20030097121A1 (en) * 2001-10-24 2003-05-22 Claude Jolly Implantable fluid delivery apparatuses and implantable electrode
US6572609B1 (en) 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US6572612B2 (en) 1999-04-05 2003-06-03 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US6595989B1 (en) 1999-05-11 2003-07-22 Atrionix, Inc. Balloon anchor wire
US6635054B2 (en) 2000-07-13 2003-10-21 Transurgical, Inc. Thermal treatment methods and apparatus with focused energy application
US6635027B1 (en) * 1997-05-19 2003-10-21 Micro Therepeutics, Inc. Method and apparatus for intramural delivery of a substance
US6641553B1 (en) 1999-06-02 2003-11-04 Boston Scientific Corporation Devices and methods for delivering a drug
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6660002B1 (en) 1993-11-08 2003-12-09 Rita Medical Systems, Inc. RF treatment apparatus
US20030236443A1 (en) 2002-04-19 2003-12-25 Cespedes Eduardo Ignacio Methods and apparatus for the identification and stabilization of vulnerable plaque
EP1382366A1 (en) 2002-07-16 2004-01-21 Possis Medical, Inc. Rapid exchange fluid jet thrombectomy device and method
US6736811B2 (en) 1996-01-19 2004-05-18 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US6743226B2 (en) 2001-02-09 2004-06-01 Cosman Company, Inc. Adjustable trans-urethral radio-frequency ablation
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
US6780183B2 (en) 2002-09-16 2004-08-24 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
US6808524B2 (en) 2002-09-16 2004-10-26 Prorhythm, Inc. Balloon alignment and collapsing system
US6814730B2 (en) 2001-10-09 2004-11-09 Hong Li Balloon catheters for non-continuous lesions
US6869431B2 (en) 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
WO2005025645A2 (en) 2003-09-08 2005-03-24 Ash Access Technology, Inc. Anti-clotting indwelling catheter
US6872183B2 (en) 1999-11-10 2005-03-29 Cytyc Surgical Product System and method for detecting perforations in a body cavity
US6872206B2 (en) 1998-02-19 2005-03-29 Curon Medical, Inc. Methods for treating the cardia of the stomach
US6911027B1 (en) 1997-08-15 2005-06-28 Somnus Medical Technologies, Inc. Device for the ablation of tissue
US6964649B2 (en) 1999-12-08 2005-11-15 Boston Scientific Scimed., Inc. Needle-less injection apparatus and method
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US20060041277A1 (en) 2002-04-08 2006-02-23 Mark Deem Methods and apparatus for renal neuromodulation
US7004923B2 (en) * 1999-07-19 2006-02-28 I-Flow Corporation Catheter for uniform delivery of medication
US20060100618A1 (en) 2004-11-08 2006-05-11 Cardima, Inc. System and method for performing ablation and other medical procedures using an electrode array with flex circuit
US7048733B2 (en) 2003-09-19 2006-05-23 Baylis Medical Company Inc. Surgical perforation device with curve
WO2006078444A1 (en) 2005-01-21 2006-07-27 Boston Scientific Limited Delivery of therapeutic through multiple delivery members
US20060206150A1 (en) 2002-04-08 2006-09-14 Ardian, Inc. Methods and apparatus for treating acute myocardial infarction
US7115122B1 (en) 1993-10-15 2006-10-03 Ep Technologies, Inc. Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like
US20060247701A1 (en) 2003-11-06 2006-11-02 Medtronic, Inc. Inotropic Orthorhythmic Cardiac Stimulator
US7137395B2 (en) 2000-02-29 2006-11-21 The Johns Hopkins University Circumferential pulmonary vein ablation using a laser and fiberoptic balloon catheter
US20060265014A1 (en) 2002-04-08 2006-11-23 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US20060265015A1 (en) 2002-04-08 2006-11-23 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US20060276852A1 (en) 2002-04-08 2006-12-07 Ardian, Inc. Methods and apparatus for treating hypertension
US7150745B2 (en) 2004-01-09 2006-12-19 Barrx Medical, Inc. Devices and methods for treatment of luminal tissue
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US20070060888A1 (en) * 2005-09-06 2007-03-15 Kerberos Proximal Solutions, Inc. Methods and apparatus for assisted aspiration
US7207984B2 (en) 1999-07-14 2007-04-24 Cardiofocus, Inc. Methods for projection of energy
US20070112422A1 (en) 2005-11-16 2007-05-17 Mark Dehdashtian Transapical heart valve delivery system and method
US7220269B1 (en) * 2003-11-06 2007-05-22 Possis Medical, Inc. Thrombectomy catheter system with occluder and method of using same
US20070118094A1 (en) 2005-05-03 2007-05-24 John Bingham Needle-less injector and method of fluid delivery
US7226448B2 (en) 2001-12-04 2007-06-05 Estech, Inc. (Endoscopic Technologies, Inc.) Cardiac treatment devices and methods
US20070129760A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods and apparatus for intravasculary-induced neuromodulation or denervation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7232437B2 (en) 2003-10-30 2007-06-19 Medical Cv, Inc. Assessment of lesion transmurality
US7238179B2 (en) 2003-10-30 2007-07-03 Medical Cv, Inc. Apparatus and method for guided ablation treatment
US7238180B2 (en) 2003-10-30 2007-07-03 Medicalcv Inc. Guided ablation with end-fire fiber
US7267674B2 (en) 2003-10-30 2007-09-11 Medical Cv, Inc. Apparatus and method for laser treatment
US20070213671A1 (en) * 2005-09-07 2007-09-13 Hiatt Mark J Infusion catheter system with telescoping cannula
US20070225634A1 (en) 2004-04-19 2007-09-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Lumen-traveling delivery device
US20070244501A1 (en) 2006-04-18 2007-10-18 Horn Daniel J Medical balloons
US7286866B2 (en) 2001-11-05 2007-10-23 Ge Medical Systems Global Technology Company, Llc Method, system and computer product for cardiac interventional procedure planning
US7291146B2 (en) 2003-09-12 2007-11-06 Minnow Medical, Inc. Selectable eccentric remodeling and/or ablation of atherosclerotic material
US7310150B2 (en) 2002-01-11 2007-12-18 The General Hospital Corporation Apparatus and method for low coherence ranging
US7320677B2 (en) 2000-10-20 2008-01-22 Société de Commercialisation des Produits de la Recherche Appliquée - Socpra Sciences et Génie, S.E.C. Needleless syringe for the delivery of therapeutic agents
US7346381B2 (en) 2002-11-01 2008-03-18 Ge Medical Systems Global Technology Company Llc Method and apparatus for medical intervention procedure planning
US7365859B2 (en) 2004-09-10 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
US7366376B2 (en) 2004-09-29 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
US7371231B2 (en) 2004-02-02 2008-05-13 Boston Scientific Scimed, Inc. System and method for performing ablation using a balloon
US7382949B2 (en) 2004-11-02 2008-06-03 The General Hospital Corporation Fiber-optic rotational device, optical system and method for imaging a sample
US7396355B2 (en) 1997-09-11 2008-07-08 Vnus Medical Technologies, Inc. Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US7406970B2 (en) 1997-09-11 2008-08-05 Vnus Medical Technologies, Inc. Method of using expandable vein ligator catheter having multiple electrode leads
US20080188912A1 (en) 2004-09-10 2008-08-07 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
US7418169B2 (en) 2006-02-01 2008-08-26 The General Hospital Corporation Apparatus for controlling at least one of at least two sections of at least one fiber
US20080205481A1 (en) * 2007-02-22 2008-08-28 Faries Durward I Method and Apparatus for Measurement and Control of Temperature for Infused Liquids
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
US7429260B2 (en) 1996-07-16 2008-09-30 Arthrocare Corporation Systems and methods for electrosurgical tissue contraction within the spine
US7445618B2 (en) 1993-05-10 2008-11-04 Arthrocare Corporation Methods for tissue ablation using pulsed energy
US7447408B2 (en) 2004-07-02 2008-11-04 The General Hospital Corproation Imaging system and related techniques
US20080275445A1 (en) 2007-05-04 2008-11-06 Barrx Medical, Inc. Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US20080281312A1 (en) 2007-05-11 2008-11-13 Ablation Frontiers, Inc. Ablation Therapy System and Method for Treating Continuous Atrial Fibrillation
US7452358B2 (en) 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US20080296152A1 (en) 2006-03-16 2008-12-04 Axel Voss Apparatus for generating electrical discharge
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7473251B2 (en) 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20090024195A1 (en) 2005-09-12 2009-01-22 The Cleveland Clinic Foundation Method and apparatus for renal neuromodulation
US7481808B2 (en) 2004-06-30 2009-01-27 Ethicon, Inc. Flexible electrode device and surgical apparatus equipped with same
US7481809B2 (en) 1996-01-05 2009-01-27 Thermage, Inc. Handpiece with RF electrode and non-volatile memory
US7489969B2 (en) 2003-02-03 2009-02-10 Enteromedics Inc. Vagal down-regulation obesity treatment
US7507236B2 (en) 1992-01-07 2009-03-24 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US7510555B2 (en) 2004-05-07 2009-03-31 Therm Med, Llc Enhanced systems and methods for RF-induced hyperthermia
US7519096B2 (en) 2003-06-06 2009-04-14 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7529393B2 (en) 2003-03-27 2009-05-05 Koninklijke Philips Electronics, N.V. Guidance of invasive medical devices by wide view three dimensional ultrasonic imaging
US7538859B2 (en) 2006-02-01 2009-05-26 The General Hospital Corporation Methods and systems for monitoring and obtaining information of at least one portion of a sample using conformal laser therapy procedures, and providing electromagnetic radiation thereto
WO2009067695A1 (en) 2007-11-21 2009-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Methods and system for occluding vessels during cardiac ablation
US20090227885A1 (en) 2007-10-12 2009-09-10 Guy Russell Lowery Apparatus and Methods for the Measurement of Cardiac Output
US20090240249A1 (en) 2004-11-08 2009-09-24 Cardima, Inc. System and Method for Performing Ablation and Other Medical Procedures Using An Electrode Array with Flexible Circuit
US20090254142A1 (en) 2008-04-08 2009-10-08 Silhouette Medical, Usa Treating Medical Conditions of Hollow Organs
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20090312754A1 (en) 2008-06-13 2009-12-17 Lenihan Timothy J Method and apparatus for measuring catheter contact force during a medical procedure
US20090312696A1 (en) 2005-12-28 2009-12-17 Copa Vincent G Devices, Systems, and Related Methods for Delivery of Fluid to Tissue
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7669309B2 (en) 2003-09-22 2010-03-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing a medical device having integral traces and formed electrodes
WO2010065133A2 (en) 2008-12-05 2010-06-10 Ams Research Corporation Devices, systems, and related methods for delivery of fluid to tissue
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20100204560A1 (en) 2008-11-11 2010-08-12 Amr Salahieh Low profile electrode assembly
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US20100331776A1 (en) 2009-06-24 2010-12-30 Amr Salahieh Steerable Medical Delivery Devices and Methods of Use
US20110046600A1 (en) 2008-12-05 2011-02-24 Crank Justin M Devices, systems, and related methods for delivery of fluid to tissue
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US20110104060A1 (en) 2009-04-22 2011-05-05 Mercator Medsystems, Inc. Treatment of hypertension by renal vascular delivery of guanethidine
EP2335757A2 (en) 2009-12-03 2011-06-22 Gold Nanotech, Inc. Needleless drug delivery device
US20130138082A1 (en) 2010-03-24 2013-05-30 Amr Salahieh Intravascular Tissue Disruption

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021320A1 (en) * 1993-03-15 1994-09-29 Advanced Cardiovascular Systems, Inc. Fluid delivery catheter
US6203513B1 (en) * 1997-11-20 2001-03-20 Optonol Ltd. Flow regulating implant, method of manufacture, and delivery device
US6969373B2 (en) * 2001-04-13 2005-11-29 Tricardia, Llc Syringe system
WO2004034767A2 (en) * 2002-09-20 2004-04-29 Flowmedica, Inc. Catheter system for renal therapy
DE10348832A1 (de) * 2003-09-30 2006-05-18 Erbe Elektromedizin Gmbh Fördereinrichtung für sterile Medien
JP2009522010A (ja) * 2005-12-28 2009-06-11 エーエムエス リサーチ コーポレイション 組織へ流体を供与する装置、システムおよび関連方法
US20080119823A1 (en) * 2006-11-21 2008-05-22 Crank Justin M Injection Tube for Jet Injection Device
JP4311483B2 (ja) * 2007-08-10 2009-08-12 セイコーエプソン株式会社 液体噴射装置およびそれを用いた手術器具

Patent Citations (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692139A (en) 1984-03-09 1987-09-08 Stiles Frank B Catheter for effecting removal of obstructions from a biological duct
US4547193A (en) 1984-04-05 1985-10-15 Angiomedics Incorporated Catheter having embedded multi-apertured film
US4634432A (en) 1985-05-13 1987-01-06 Nuri Kocak Introducer sheath assembly
US4726382A (en) 1986-09-17 1988-02-23 The Boc Group, Inc. Inflatable finger cuff
US5041089A (en) 1987-12-11 1991-08-20 Devices For Vascular Intervention, Inc. Vascular dilation catheter construction
US4890623A (en) 1988-03-14 1990-01-02 C. R. Bard, Inc. Biopotential sensing device and method for making
US5715825A (en) 1988-03-21 1998-02-10 Boston Scientific Corporation Acoustic imaging catheter and the like
US5069674A (en) 1988-11-23 1991-12-03 Medical Engineering And Development Institute, Inc. Flexible, kink-resistant catheter
US5779698A (en) 1989-01-18 1998-07-14 Applied Medical Resources Corporation Angioplasty catheter system and method for making same
US5343860A (en) 1989-02-06 1994-09-06 Arzco Medical Systems, Inc. Esophageal recording/pacing catheter with thermistor and cardiac imaging transceiver
US4968306A (en) * 1989-07-07 1990-11-06 Advanced Cardiovascular Systems, Inc. Intravascular catheter having an adjustable length infusion section to delivery therapeutic fluid
US5010895A (en) 1989-08-03 1991-04-30 Empi, Inc. Expandable vaginal electrode
DE4104092A1 (de) 1990-02-13 1991-08-14 Christoph Dr Med Rieger Von einem flexiblen kunststoffschlauch ueberzogene metallkanuele
US5180376A (en) 1990-05-01 1993-01-19 Cathco, Inc. Non-buckling thin-walled sheath for the percutaneous insertion of intraluminal catheters
US6471683B2 (en) * 1990-08-06 2002-10-29 Possis Medical, Inc. Thrombectomy and tissue removal method
US5496267A (en) * 1990-11-08 1996-03-05 Possis Medical, Inc. Asymmetric water jet atherectomy
US5228442A (en) 1991-02-15 1993-07-20 Cardiac Pathways Corporation Method for mapping, ablation, and stimulation using an endocardial catheter
US5213576A (en) * 1991-06-11 1993-05-25 Cordis Corporation Therapeutic porous balloon catheter
US5209741A (en) 1991-07-08 1993-05-11 Endomedix Corporation Surgical access device having variable post-insertion cross-sectional geometry
US5573520A (en) 1991-09-05 1996-11-12 Mayo Foundation For Medical Education And Research Flexible tubular device for use in medical applications
US5524338A (en) 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
US5515848A (en) 1991-10-22 1996-05-14 Pi Medical Corporation Implantable microelectrode
US7507236B2 (en) 1992-01-07 2009-03-24 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US5306250A (en) * 1992-04-02 1994-04-26 Indiana University Foundation Method and apparatus for intravascular drug delivery
US5562720A (en) 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
EP0637943B1 (en) 1992-05-01 1998-04-01 Vesta Medical, Inc. Endometrial ablation apparatus
US5311866A (en) 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
US6052607A (en) 1992-09-25 2000-04-18 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5309910A (en) 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5391200A (en) 1992-09-30 1995-02-21 Cardiac Pacemakers, Inc. Defibrillation patch electrode having conductor-free resilient zone for minimally invasive deployment
US5540679A (en) 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US5571086A (en) * 1992-11-02 1996-11-05 Localmed, Inc. Method and apparatus for sequentially performing multiple intraluminal procedures
US5713860A (en) * 1992-11-02 1998-02-03 Localmed, Inc. Intravascular catheter with infusion array
US5609574A (en) * 1992-11-02 1997-03-11 Localmed, Inc. Intravascular catheter with infusion array
US5609606A (en) 1993-02-05 1997-03-11 Joe W. & Dorothy Dorsett Brown Foundation Ultrasonic angioplasty balloon catheter
US6460545B2 (en) 1993-03-16 2002-10-08 Ep Technologies, Inc. Medical device with three dimensional collapsible basket structure
EP0693955B1 (en) 1993-04-14 2003-01-02 Sherwood Services AG Apparatus for endometrial ablation
US7445618B2 (en) 1993-05-10 2008-11-04 Arthrocare Corporation Methods for tissue ablation using pulsed energy
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
US5575772A (en) 1993-07-01 1996-11-19 Boston Scientific Corporation Albation catheters
US5630837A (en) 1993-07-01 1997-05-20 Boston Scientific Corporation Acoustic ablation
US5860974A (en) 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US6004269A (en) 1993-07-01 1999-12-21 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US5718701A (en) 1993-08-11 1998-02-17 Electro-Catheter Corporation Ablation electrode
EP0723467B1 (en) 1993-10-14 2002-04-17 Sherwood Services AG Bipolar/monopolar endometrial ablation device
US7115122B1 (en) 1993-10-15 2006-10-03 Ep Technologies, Inc. Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like
US7413568B2 (en) 1993-10-15 2008-08-19 Ep Technologies, Inc. Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like
US5991650A (en) 1993-10-15 1999-11-23 Ep Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
US6660002B1 (en) 1993-11-08 2003-12-09 Rita Medical Systems, Inc. RF treatment apparatus
US5792118A (en) 1994-03-07 1998-08-11 Kurth; Paul A. Permanent catheter with an exterior balloon valve and method of using the same
US5531679A (en) * 1994-03-14 1996-07-02 Schulman; Joseph H. Fluidic infusion system for catheter or probe
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5569241A (en) 1994-06-24 1996-10-29 Vidacare, Inc. Thin layer ablation apparatus
US5575788A (en) 1994-06-24 1996-11-19 Stuart D. Edwards Thin layer ablation apparatus
US5769846A (en) 1994-06-24 1998-06-23 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5558672A (en) 1994-06-24 1996-09-24 Vidacare, Inc. Thin layer ablation apparatus
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5735846A (en) 1994-06-27 1998-04-07 Ep Technologies, Inc. Systems and methods for ablating body tissue using predicted maximum tissue temperature
US5626564A (en) * 1995-03-31 1997-05-06 Creighton University Adjustable sideholes catheter
US5846196A (en) 1995-12-13 1998-12-08 Cordis Europa N.V. Intravascular multielectrode cardiac mapping probe
US7452358B2 (en) 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US7473251B2 (en) 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US7481809B2 (en) 1996-01-05 2009-01-27 Thermage, Inc. Handpiece with RF electrode and non-volatile memory
US5961513A (en) 1996-01-19 1999-10-05 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures
US5846238A (en) 1996-01-19 1998-12-08 Ep Technologies, Inc. Expandable-collapsible electrode structures with distal end steering or manipulation
US5871483A (en) 1996-01-19 1999-02-16 Ep Technologies, Inc. Folding electrode structures
US6736811B2 (en) 1996-01-19 2004-05-18 Ep Technologies, Inc. Expandable-collapsible electrode structures made of electrically conductive material
US5853411A (en) 1996-01-19 1998-12-29 Ep Technologies, Inc. Enhanced electrical connections for electrode structures
US5836874A (en) 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5879348A (en) 1996-04-12 1999-03-09 Ep Technologies, Inc. Electrode structures formed from flexible, porous, or woven materials
US5846239A (en) 1996-04-12 1998-12-08 Ep Technologies, Inc. Tissue heating and ablation systems and methods using segmented porous electrode structures
US6292689B1 (en) 1996-04-17 2001-09-18 Imagyn Medical Technologies California, Inc. Apparatus and methods of bioelectrical impedance analysis of blood flow
US7429260B2 (en) 1996-07-16 2008-09-30 Arthrocare Corporation Systems and methods for electrosurgical tissue contraction within the spine
US5904651A (en) 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US6206912B1 (en) 1996-11-07 2001-03-27 St. Jude Medical Anastomotic Technology Group Inc. Medical grafting methods and apparatus
US5800408A (en) * 1996-11-08 1998-09-01 Micro Therapeutics, Inc. Infusion device for distributing infusate along an elongated infusion segment
US6402746B1 (en) 1996-12-19 2002-06-11 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US6635027B1 (en) * 1997-05-19 2003-10-21 Micro Therepeutics, Inc. Method and apparatus for intramural delivery of a substance
US5882332A (en) 1997-06-06 1999-03-16 Wijay; Bandula Drug infusion catheter and method
WO1999000060A1 (en) 1997-06-26 1999-01-07 Advanced Coronary Intervention Electrosurgical catheter for resolving obstructions by radio frequency ablation
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5888577A (en) 1997-06-30 1999-03-30 Procath Corporation Method for forming an electrophysiology catheter
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6869431B2 (en) 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6911027B1 (en) 1997-08-15 2005-06-28 Somnus Medical Technologies, Inc. Device for the ablation of tissue
US7406970B2 (en) 1997-09-11 2008-08-05 Vnus Medical Technologies, Inc. Method of using expandable vein ligator catheter having multiple electrode leads
US7396355B2 (en) 1997-09-11 2008-07-08 Vnus Medical Technologies, Inc. Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US20020002384A1 (en) 1997-11-07 2002-01-03 Paul Gilson Embolic protection device
US6872206B2 (en) 1998-02-19 2005-03-29 Curon Medical, Inc. Methods for treating the cardia of the stomach
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
WO1999048545A1 (en) 1998-03-25 1999-09-30 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6558378B2 (en) 1998-05-05 2003-05-06 Cardiac Pacemakers, Inc. RF ablation system and method having automatic temperature control
US6163726A (en) 1998-09-21 2000-12-19 The General Hospital Corporation Selective ablation of glandular tissue
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6572612B2 (en) 1999-04-05 2003-06-03 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
WO2000066014A1 (en) 1999-04-29 2000-11-09 Somnus Medical Technologies, Inc. Device for the ablation of tissue
US6595989B1 (en) 1999-05-11 2003-07-22 Atrionix, Inc. Balloon anchor wire
US6641553B1 (en) 1999-06-02 2003-11-04 Boston Scientific Corporation Devices and methods for delivering a drug
US7357796B2 (en) 1999-07-14 2008-04-15 Cardiofocus Corporation Phototherapeutic wave guide apparatus
US6572609B1 (en) 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US7207984B2 (en) 1999-07-14 2007-04-24 Cardiofocus, Inc. Methods for projection of energy
US6942657B2 (en) 1999-07-14 2005-09-13 Cardiofocus, Inc. Intralumenal contact sensor
US7004923B2 (en) * 1999-07-19 2006-02-28 I-Flow Corporation Catheter for uniform delivery of medication
US6872183B2 (en) 1999-11-10 2005-03-29 Cytyc Surgical Product System and method for detecting perforations in a body cavity
US6964649B2 (en) 1999-12-08 2005-11-15 Boston Scientific Scimed., Inc. Needle-less injection apparatus and method
US7137395B2 (en) 2000-02-29 2006-11-21 The Johns Hopkins University Circumferential pulmonary vein ablation using a laser and fiberoptic balloon catheter
US6635054B2 (en) 2000-07-13 2003-10-21 Transurgical, Inc. Thermal treatment methods and apparatus with focused energy application
US20020095147A1 (en) 2000-08-16 2002-07-18 Shadduck John H. Electrical discharge catheter system for extracting emboli in endovascular interventions
US7320677B2 (en) 2000-10-20 2008-01-22 Société de Commercialisation des Produits de la Recherche Appliquée - Socpra Sciences et Génie, S.E.C. Needleless syringe for the delivery of therapeutic agents
US6743226B2 (en) 2001-02-09 2004-06-01 Cosman Company, Inc. Adjustable trans-urethral radio-frequency ablation
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
US6814730B2 (en) 2001-10-09 2004-11-09 Hong Li Balloon catheters for non-continuous lesions
US20030097121A1 (en) * 2001-10-24 2003-05-22 Claude Jolly Implantable fluid delivery apparatuses and implantable electrode
US7286866B2 (en) 2001-11-05 2007-10-23 Ge Medical Systems Global Technology Company, Llc Method, system and computer product for cardiac interventional procedure planning
US7226448B2 (en) 2001-12-04 2007-06-05 Estech, Inc. (Endoscopic Technologies, Inc.) Cardiac treatment devices and methods
US7310150B2 (en) 2002-01-11 2007-12-18 The General Hospital Corporation Apparatus and method for low coherence ranging
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20060206150A1 (en) 2002-04-08 2006-09-14 Ardian, Inc. Methods and apparatus for treating acute myocardial infarction
US20060276852A1 (en) 2002-04-08 2006-12-07 Ardian, Inc. Methods and apparatus for treating hypertension
US20060265015A1 (en) 2002-04-08 2006-11-23 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US20060265014A1 (en) 2002-04-08 2006-11-23 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US20060212078A1 (en) 2002-04-08 2006-09-21 Ardian, Inc. Methods and apparatus for treating congestive heart failure
US20060212076A1 (en) 2002-04-08 2006-09-21 Ardian, Inc. Methods and apparatus for treating end-stage renal disease
US20060271111A1 (en) 2002-04-08 2006-11-30 Ardian, Inc. Methods and apparatus for treating contrast nephropathy
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20070129760A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods and apparatus for intravasculary-induced neuromodulation or denervation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US20060041277A1 (en) 2002-04-08 2006-02-23 Mark Deem Methods and apparatus for renal neuromodulation
US20030236443A1 (en) 2002-04-19 2003-12-25 Cespedes Eduardo Ignacio Methods and apparatus for the identification and stabilization of vulnerable plaque
EP1382366A1 (en) 2002-07-16 2004-01-21 Possis Medical, Inc. Rapid exchange fluid jet thrombectomy device and method
US6780183B2 (en) 2002-09-16 2004-08-24 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
US6808524B2 (en) 2002-09-16 2004-10-26 Prorhythm, Inc. Balloon alignment and collapsing system
US7346381B2 (en) 2002-11-01 2008-03-18 Ge Medical Systems Global Technology Company Llc Method and apparatus for medical intervention procedure planning
US7489969B2 (en) 2003-02-03 2009-02-10 Enteromedics Inc. Vagal down-regulation obesity treatment
US7529393B2 (en) 2003-03-27 2009-05-05 Koninklijke Philips Electronics, N.V. Guidance of invasive medical devices by wide view three dimensional ultrasonic imaging
US7519096B2 (en) 2003-06-06 2009-04-14 The General Hospital Corporation Process and apparatus for a wavelength tuning source
WO2005025645A2 (en) 2003-09-08 2005-03-24 Ash Access Technology, Inc. Anti-clotting indwelling catheter
US7291146B2 (en) 2003-09-12 2007-11-06 Minnow Medical, Inc. Selectable eccentric remodeling and/or ablation of atherosclerotic material
US7048733B2 (en) 2003-09-19 2006-05-23 Baylis Medical Company Inc. Surgical perforation device with curve
US7669309B2 (en) 2003-09-22 2010-03-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing a medical device having integral traces and formed electrodes
US7238179B2 (en) 2003-10-30 2007-07-03 Medical Cv, Inc. Apparatus and method for guided ablation treatment
US7238180B2 (en) 2003-10-30 2007-07-03 Medicalcv Inc. Guided ablation with end-fire fiber
US7267674B2 (en) 2003-10-30 2007-09-11 Medical Cv, Inc. Apparatus and method for laser treatment
US7232437B2 (en) 2003-10-30 2007-06-19 Medical Cv, Inc. Assessment of lesion transmurality
US7220269B1 (en) * 2003-11-06 2007-05-22 Possis Medical, Inc. Thrombectomy catheter system with occluder and method of using same
US20060247701A1 (en) 2003-11-06 2006-11-02 Medtronic, Inc. Inotropic Orthorhythmic Cardiac Stimulator
US20070078507A1 (en) 2003-11-06 2007-04-05 Fred Zacouto Process for Preparing Cells for Therapeutic and/or Prophylactic Reimplantation
US7150745B2 (en) 2004-01-09 2006-12-19 Barrx Medical, Inc. Devices and methods for treatment of luminal tissue
US7371231B2 (en) 2004-02-02 2008-05-13 Boston Scientific Scimed, Inc. System and method for performing ablation using a balloon
US20070225634A1 (en) 2004-04-19 2007-09-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Lumen-traveling delivery device
US7510555B2 (en) 2004-05-07 2009-03-31 Therm Med, Llc Enhanced systems and methods for RF-induced hyperthermia
US7481808B2 (en) 2004-06-30 2009-01-27 Ethicon, Inc. Flexible electrode device and surgical apparatus equipped with same
US7447408B2 (en) 2004-07-02 2008-11-04 The General Hospital Corproation Imaging system and related techniques
US20080188912A1 (en) 2004-09-10 2008-08-07 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
US7365859B2 (en) 2004-09-10 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
US7366376B2 (en) 2004-09-29 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US7382949B2 (en) 2004-11-02 2008-06-03 The General Hospital Corporation Fiber-optic rotational device, optical system and method for imaging a sample
US20060100618A1 (en) 2004-11-08 2006-05-11 Cardima, Inc. System and method for performing ablation and other medical procedures using an electrode array with flex circuit
US20090240249A1 (en) 2004-11-08 2009-09-24 Cardima, Inc. System and Method for Performing Ablation and Other Medical Procedures Using An Electrode Array with Flexible Circuit
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
WO2006078444A1 (en) 2005-01-21 2006-07-27 Boston Scientific Limited Delivery of therapeutic through multiple delivery members
US20110077579A1 (en) * 2005-03-24 2011-03-31 Harrison William V Cochlear implant with localized fluid transport
US20070118094A1 (en) 2005-05-03 2007-05-24 John Bingham Needle-less injector and method of fluid delivery
US20070060888A1 (en) * 2005-09-06 2007-03-15 Kerberos Proximal Solutions, Inc. Methods and apparatus for assisted aspiration
US20070213671A1 (en) * 2005-09-07 2007-09-13 Hiatt Mark J Infusion catheter system with telescoping cannula
US20090024195A1 (en) 2005-09-12 2009-01-22 The Cleveland Clinic Foundation Method and apparatus for renal neuromodulation
US20070112422A1 (en) 2005-11-16 2007-05-17 Mark Dehdashtian Transapical heart valve delivery system and method
US20090312696A1 (en) 2005-12-28 2009-12-17 Copa Vincent G Devices, Systems, and Related Methods for Delivery of Fluid to Tissue
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US7418169B2 (en) 2006-02-01 2008-08-26 The General Hospital Corporation Apparatus for controlling at least one of at least two sections of at least one fiber
US7538859B2 (en) 2006-02-01 2009-05-26 The General Hospital Corporation Methods and systems for monitoring and obtaining information of at least one portion of a sample using conformal laser therapy procedures, and providing electromagnetic radiation thereto
US20080296152A1 (en) 2006-03-16 2008-12-04 Axel Voss Apparatus for generating electrical discharge
US20070244501A1 (en) 2006-04-18 2007-10-18 Horn Daniel J Medical balloons
US20080205481A1 (en) * 2007-02-22 2008-08-28 Faries Durward I Method and Apparatus for Measurement and Control of Temperature for Infused Liquids
US20080275445A1 (en) 2007-05-04 2008-11-06 Barrx Medical, Inc. Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US20080281322A1 (en) 2007-05-11 2008-11-13 Ablation Frontiers, Inc. RF Energy Delivery System and Method
US20080281312A1 (en) 2007-05-11 2008-11-13 Ablation Frontiers, Inc. Ablation Therapy System and Method for Treating Continuous Atrial Fibrillation
US20090227885A1 (en) 2007-10-12 2009-09-10 Guy Russell Lowery Apparatus and Methods for the Measurement of Cardiac Output
WO2009067695A1 (en) 2007-11-21 2009-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Methods and system for occluding vessels during cardiac ablation
US20090254142A1 (en) 2008-04-08 2009-10-08 Silhouette Medical, Usa Treating Medical Conditions of Hollow Organs
WO2009132137A1 (en) 2008-04-23 2009-10-29 Silhouette Medical Inc. Treating medical conditions of hollow organs
US20090312754A1 (en) 2008-06-13 2009-12-17 Lenihan Timothy J Method and apparatus for measuring catheter contact force during a medical procedure
US20100204560A1 (en) 2008-11-11 2010-08-12 Amr Salahieh Low profile electrode assembly
WO2010065133A2 (en) 2008-12-05 2010-06-10 Ams Research Corporation Devices, systems, and related methods for delivery of fluid to tissue
US20110046600A1 (en) 2008-12-05 2011-02-24 Crank Justin M Devices, systems, and related methods for delivery of fluid to tissue
US20110104060A1 (en) 2009-04-22 2011-05-05 Mercator Medsystems, Inc. Treatment of hypertension by renal vascular delivery of guanethidine
US20110104061A1 (en) 2009-04-22 2011-05-05 Mercator Medsystems, Inc. Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation
US20100331776A1 (en) 2009-06-24 2010-12-30 Amr Salahieh Steerable Medical Delivery Devices and Methods of Use
EP2335757A2 (en) 2009-12-03 2011-06-22 Gold Nanotech, Inc. Needleless drug delivery device
US20130138082A1 (en) 2010-03-24 2013-05-30 Amr Salahieh Intravascular Tissue Disruption

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Drafts, Bill; Acoustic wave technology sensors; Sensors Weekly (Questex Media Group); 10 pgs.; Oct. 1, 2000 (http://www.sensorsmag.com/sensors/acoustic-ultrasound/acoustic-wave-technology-sensors-936).
Salahieh et al.; U.S. Appl. No. 13/106,658 entitled "Low Profile Electrode Assembly ," filed May 12, 2011.
Salahieh et al.; U.S. Appl. No. 13/351,962 entitled "Intravascular Tissue Disruption," filed Jan. 17, 2012.
Salahieh et al.; U.S. Appl. No. 13/830,624 entitled "Local Sympathectomy for PVD," filed Mar. 14, 2013.
Salahieh et al.; U.S. Appl. No. 13/943,633 entitled "Low Profile Electrode Assembly," filed Jul. 16, 2013.
Salahieh et al.; U.S. Appl. No. 14/023,343 entitled "Steerable Delivery Sheaths," filed Sep. 11, 2013.
Salahieh et al.; U.S. Appl. No. 61/622,495 entitled "Energy Delivery Device with Rapid Exchange Features," filed Apr. 10, 2012.
Salahieh et al.; U.S. Appl. No. 61/624,206 entitled "Energy delivery device and methods of use," filed Apr. 13, 2012.

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
US11744639B2 (en) 2008-11-11 2023-09-05 Shifamed Holdings Llc Ablation catheters
US10251700B2 (en) 2008-11-11 2019-04-09 Shifamed Holdings, Llc Ablation catheters
US9586025B2 (en) 2009-06-24 2017-03-07 Shifamed Holdings, Llc Steerable delivery sheaths
US10188832B2 (en) 2009-06-24 2019-01-29 Shifamed Holdings, Llc Steerable delivery sheaths
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
US11382689B2 (en) 2012-11-02 2022-07-12 Neurotronic, Inc. Chemical ablation formulations and methods of treatments for various diseases
US11684417B2 (en) 2012-11-02 2023-06-27 Neurotronic, Inc. Chemical ablation formulations and methods of treatments for various diseases
US11517725B2 (en) * 2012-11-02 2022-12-06 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
US12082868B2 (en) 2012-11-13 2024-09-10 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
US9333031B2 (en) 2013-04-08 2016-05-10 Apama Medical, Inc. Visualization inside an expandable medical device
US11439298B2 (en) 2013-04-08 2022-09-13 Boston Scientific Scimed, Inc. Surface mapping and visualizing ablation system
US11684415B2 (en) 2013-04-08 2023-06-27 Boston Scientific Scimed, Inc. Tissue ablation and monitoring thereof
US10349824B2 (en) 2013-04-08 2019-07-16 Apama Medical, Inc. Tissue mapping and visualization systems
US12005207B2 (en) 2014-10-30 2024-06-11 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
US11648378B2 (en) 2014-10-30 2023-05-16 Neurotronic, Inc. Chemical ablation and method of treatment for various diseases
US10420537B2 (en) 2015-03-27 2019-09-24 Shifamed Holdings, Llc Steerable medical devices, systems, and methods of use
US11052226B2 (en) 2015-04-24 2021-07-06 Kalila Medical, Inc. Steerable medical devices, systems, and methods of use
US10933221B2 (en) 2015-11-09 2021-03-02 Kalila Medical, Inc. Steering assemblies for medical devices, and methods of use
US10736693B2 (en) 2015-11-16 2020-08-11 Apama Medical, Inc. Energy delivery devices
US11529497B1 (en) 2022-01-13 2022-12-20 Orlando Health, Inc. Centering device for a catheter

Also Published As

Publication number Publication date
CN102917748A (zh) 2013-02-06
CN102917748B (zh) 2015-04-01
AU2018201235A1 (en) 2018-03-15
US20120116438A1 (en) 2012-05-10
US20170080184A1 (en) 2017-03-23
AU2011232335A1 (en) 2012-10-11
EP2550040A4 (en) 2014-03-26
WO2011119857A3 (en) 2012-04-19
CA2793737A1 (en) 2011-09-29
AU2016203340A1 (en) 2016-06-30
JP2013521995A (ja) 2013-06-13
EP2550040A2 (en) 2013-01-30
WO2011119857A2 (en) 2011-09-29
US20110257622A1 (en) 2011-10-20
AU2016203340B2 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
AU2016203340B2 (en) Intravascular tissue disruption
JP7333361B2 (ja) 瘻を形成するためのデバイスおよび方法
JP7093744B2 (ja) 支持構造を備えた脈管周囲組織焼灼カテーテル
EP4074274B1 (en) Low profile catheter assemblies
JP2019122807A (ja) 体内通路を通る流体の流れを提供又は維持する方法及びシステム
JP2008535605A (ja) ヒトまたは動物組織の全部または一部に特に伝熱流体を注入するための埋め込み可能な管
WO2000067825A1 (en) Apparatus and method for delivering therapeutic and diagnostic agents
KR102576604B1 (ko) 의료용 정밀 약물주입 및 전기천공 융합 전극

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHIFAMED, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SALAHIEH, AMR;SCHAER, ALAN;KROLIK, JEFF;AND OTHERS;SIGNING DATES FROM 20110415 TO 20110706;REEL/FRAME:027299/0281

AS Assignment

Owner name: SHIFAMED HOLDINGS, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHIFAMED, LLC;REEL/FRAME:027555/0611

Effective date: 20111129

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551)

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: 7.5 YR SURCHARGE - LATE PMT W/IN 6 MO, LARGE ENTITY (ORIGINAL EVENT CODE: M1555); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8